DE2500076C3
(de)
|
1975-01-02 |
1982-11-18 |
SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld |
Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4634665A
(en)
*
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US5179017A
(en)
*
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
NO812612L
(no)
|
1980-08-06 |
1982-02-08 |
Ferring Pharma Ltd |
Enzym-inhibitorer.
|
WO1982001011A1
(fr)
|
1980-09-24 |
1982-04-01 |
Corp Cetus |
Procede et sonde de diagnostic
|
US4582788A
(en)
|
1982-01-22 |
1986-04-15 |
Cetus Corporation |
HLA typing method and cDNA probes used therein
|
EP0084796B1
(fr)
|
1982-01-22 |
1990-05-02 |
Cetus Corporation |
Procédé pour la caractérisation de HLA et sondes de cADN pour sa mise en oeuvre
|
US4510245A
(en)
*
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
GB8308235D0
(en)
*
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4526039A
(en)
|
1983-06-23 |
1985-07-02 |
The United States Of America As Represented By The Secretary Of Transportation |
Removable strain gauge fixture and method for measuring accumulated strain in a material
|
US4683194A
(en)
|
1984-05-29 |
1987-07-28 |
Cetus Corporation |
Method for detection of polymorphic restriction sites and nucleic acid sequences
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
DE3588239T3
(de)
|
1985-03-30 |
2007-03-08 |
Kauffman, Stuart A., Santa Fe |
Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
US5618920A
(en)
*
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
CA1284931C
(fr)
|
1986-03-13 |
1991-06-18 |
Henry A. Erlich |
Procede de detection de variations specifiques de nucleotides et de polymorphismes genetiques dans les acides nucleiques
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
US5107065A
(en)
|
1986-03-28 |
1992-04-21 |
Calgene, Inc. |
Anti-sense regulation of gene expression in plant cells
|
CA1338457C
(fr)
|
1986-08-22 |
1996-07-16 |
Henry A. Erlich |
Enzyme thermostable purifiee
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
US5525339A
(en)
|
1986-08-27 |
1996-06-11 |
Dms Pharmaceutical Inc. |
Isolated components of dense microspheres derived from mammalian brain tissue and antibodies thereto
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5811310A
(en)
|
1986-09-30 |
1998-09-22 |
Albert Einstein College Of Medicine Of Yeshiva Univ. |
The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
|
JPS63240797A
(ja)
|
1986-10-14 |
1988-10-06 |
Shin Etsu Chem Co Ltd |
モノクローナル抗体、その製法およびそれを含有する診断薬
|
ATE169673T1
(de)
|
1986-11-17 |
1998-08-15 |
Scios Inc |
Rekombiniertes alzheimer amyloid-protein
|
DE3702789A1
(de)
|
1987-01-30 |
1988-08-18 |
Bayer Ag |
Vorlaeuferprotein des apc-polypeptids, dafuer codierende dna und diagnostische verwendung der dna und des proteins
|
WO1988007089A1
(fr)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Anticorps alteres
|
JPS63245689A
(ja)
|
1987-03-31 |
1988-10-12 |
Suntory Ltd |
ヒトアミロイド関連蛋白モノクロ−ナル抗体
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
CA1340802C
(fr)
|
1987-08-15 |
1999-10-26 |
Yasuyuki Takahashi |
Proteine precurseur de l'amyloide senile et anticorps specifique pour cette proteine
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
CA1339014C
(fr)
|
1987-10-08 |
1997-03-25 |
Ronald E. Majocha |
Anticorps pour peptide a4-amyloide
|
JP2562623B2
(ja)
|
1987-10-28 |
1996-12-11 |
国際電信電話株式会社 |
ベースバンド合成法による偏波ダイバーシティ光受信方式
|
AU3056289A
(en)
|
1988-01-13 |
1989-08-11 |
Mclean Hospital Corporation, The |
Genetic constructs containing the alzheimer brain amyloid gene
|
AU3204689A
(en)
|
1988-02-10 |
1989-09-06 |
Children's Medical Center Corporation |
Amyloid protein precursors, genetic probes, antibodies, and methods of use
|
US5134062A
(en)
|
1988-03-22 |
1992-07-28 |
Cornell Research Foundation, Inc. |
Diagnosis of neuronal disorders and screening potential therapeutic agents therefor
|
US5015570A
(en)
|
1988-05-13 |
1991-05-14 |
Molecular Therapeutics, Inc. |
Molecular diagnosis of Alzheimer Disease
|
US6287793B1
(en)
|
1988-08-19 |
2001-09-11 |
Elan Pharmaceuticals, Inc. |
Diagnostic methods for alzheimer's disease
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
DE768377T1
(de)
|
1988-09-02 |
1998-01-02 |
Dyax Corp |
Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen
|
WO1990005144A1
(fr)
|
1988-11-11 |
1990-05-17 |
Medical Research Council |
Ligands a domaine unique, recepteurs comprenant lesdits ligands, procedes pour leur production, et emploi desdits ligands et recepteurs
|
IL162181A
(en)
†
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
US20030229208A1
(en)
|
1988-12-28 |
2003-12-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5231020A
(en)
|
1989-03-30 |
1993-07-27 |
Dna Plant Technology Corporation |
Genetic engineering of novel plant phenotypes
|
US5262332A
(en)
|
1989-04-05 |
1993-11-16 |
Brigham And Women's Hospital |
Diagnostic method for Alzheimer's disease: examination of non-neural tissue
|
AU5525090A
(en)
|
1989-04-14 |
1990-11-16 |
Research Foundation For Mental Hygiene, Inc. |
Monoclonal antibody to amyloid peptide
|
CA2016842A1
(fr)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Methode pour puiser dans le repertoire immunologique
|
AU652539B2
(en)
|
1989-05-16 |
1994-09-01 |
Medical Research Council |
Co-expression of heteromeric receptors
|
CA2016841C
(fr)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
Methode de production de polymeres ayant une activite choisie
|
US5234814A
(en)
|
1989-06-01 |
1993-08-10 |
Du Pont Merck Pharmaceutical Company |
Diagnostic assay for alzheimer's disease
|
EP0415801A1
(fr)
|
1989-07-05 |
1991-03-06 |
N.V. Innogenetics S.A. |
Anticorps monoclonaux contre cellules microglia activées
|
EP0411974A1
(fr)
|
1989-07-05 |
1991-02-06 |
N.V. Innogenetics S.A. |
Anticorps monoclonaux contre une antigène d'enchevêtrements neurofibrillaires
|
AU6430190A
(en)
|
1989-10-10 |
1991-05-16 |
Pitman-Moore, Inc. |
Sustained release composition for macromolecular proteins
|
JP2571874B2
(ja)
|
1989-11-06 |
1997-01-16 |
アルカーメス コントロールド セラピューティクス,インコーポレイテッド |
タンパク質マイクロスフェア組成物
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
EP1690935A3
(fr)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Génération d'anticorps xenogéniques
|
AU7121191A
(en)
|
1990-02-26 |
1991-10-10 |
Albert Einstein College Of Medicine Of Yeshiva University |
Diagnostic assay for alzheimer's disease
|
US5753624A
(en)
|
1990-04-27 |
1998-05-19 |
Milkhaus Laboratory, Inc. |
Materials and methods for treatment of plaquing disease
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
AU665190B2
(en)
|
1990-07-10 |
1995-12-21 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
DE4022247A1
(de)
|
1990-07-12 |
1992-01-16 |
Hoechst Ag |
Verfahren zur extraktiven abtrennung von 2-alkylthio-5-phenylpyrimidinen aus ihren reaktionsgemischen
|
CA2090126C
(fr)
|
1990-08-02 |
2002-10-22 |
John W. Schrader |
Methodes de production de proteines dotees d'une fonction desiree
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5877397A
(en)
*
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
*
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
ATE164395T1
(de)
|
1990-12-03 |
1998-04-15 |
Genentech Inc |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
JPH04252195A
(ja)
|
1991-01-29 |
1992-09-08 |
Asahi Chem Ind Co Ltd |
モノクローナル抗体及びハイブリドーマ
|
DK1820858T3
(da)
|
1991-03-01 |
2009-11-02 |
Dyax Corp |
Kimært protein omfatende mikroprotein med to eller flere disulfidbindinger og udförelsesformer deraf
|
WO1992018619A1
(fr)
|
1991-04-10 |
1992-10-29 |
The Scripps Research Institute |
Banques de recepteurs heterodimeres utilisant des phagemides
|
JPH04320694A
(ja)
|
1991-04-22 |
1992-11-11 |
Ono Pharmaceut Co Ltd |
ヒトグリア細胞増殖抑制因子に対するモノクローナル抗体
|
ATE221379T1
(de)
|
1991-05-01 |
2002-08-15 |
Jackson H M Found Military Med |
Verfahren zur behandlung infektiöser respiratorischer erkrankungen
|
JPH04342883A
(ja)
|
1991-05-17 |
1992-11-30 |
Sanden Corp |
容量可変型斜板式圧縮機
|
DE69233482T2
(de)
|
1991-05-17 |
2006-01-12 |
Merck & Co., Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
EP0590067A1
(fr)
|
1991-06-14 |
1994-04-06 |
Xoma Corporation |
Fragments d'anticorps produits par des microbes et leurs conjugues
|
WO1994004679A1
(fr)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Procede pour fabriquer des anticorps humanises
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
JP3909084B2
(ja)
|
1991-10-25 |
2007-04-25 |
エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム |
微小管結合タンパク質タウに対するモノクローナル抗体
|
US5705401A
(en)
|
1991-11-12 |
1998-01-06 |
The University Of Melbourne |
Method of assaying for alzheimer's disease
|
PT1696031E
(pt)
|
1991-12-02 |
2010-06-25 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
US20020009443A1
(en)
|
1991-12-02 |
2002-01-24 |
Vanitha Ramakrishman |
Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
|
US7408027B1
(en)
|
1991-12-06 |
2008-08-05 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften |
Tools for the diagnosis and treatment of Alzheimer's disease
|
DE69230148T2
(de)
|
1991-12-06 |
2000-05-04 |
Max Planck Gesellschaft |
Werkzeuge für die Diagnose und Behandlung der Alzheimerschen Krankheit.
|
ES2202310T3
(es)
|
1991-12-13 |
2004-04-01 |
Xoma Corporation |
Metodos y materiales para la preparacion de dominios variables de anticuerpos modificados y sus usos terapeuticos.
|
US20010029293A1
(en)
|
1992-01-27 |
2001-10-11 |
Icos Corporation |
Icam-related protein
|
US5538845A
(en)
|
1992-02-05 |
1996-07-23 |
Athena Neurosciences, Inc. |
Beta-amyloid peptide production inhibitors and methods for their identification
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
US5733743A
(en)
*
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
US5912120A
(en)
|
1992-04-09 |
1999-06-15 |
The United States Of America As Represented By The Department Of Health And Human Services, |
Cloning, expression and diagnosis of human cytochrome P450 2C19: the principal determinant of s-mephenytoin metabolism
|
US5441870A
(en)
|
1992-04-15 |
1995-08-15 |
Athena Neurosciences, Inc. |
Methods for monitoring cellular processing of β-amyloid precursor protein
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
US5455169A
(en)
|
1992-06-04 |
1995-10-03 |
Alzheimer's Institute Of America, Inc. |
Nucleic acids for diagnosing and modeling Alzheimer's disease
|
US5766846A
(en)
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
US5837672A
(en)
|
1992-07-10 |
1998-11-17 |
Athena Neurosciences, Inc. |
Methods and compositions for the detection of soluble β-amyloid peptide
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
JPH07509137A
(ja)
|
1992-07-24 |
1995-10-12 |
セル ジェネシス,インク. |
異種抗体の生産
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
TW258789B
(fr)
|
1992-09-28 |
1995-10-01 |
Rohm & Haas |
|
US5605811A
(en)
|
1992-10-26 |
1997-02-25 |
Athena Neurosciences, Inc. |
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
|
US5891623A
(en)
|
1992-11-09 |
1999-04-06 |
Consorzio Per Le Biotecnologie |
Diagnosis and treatment of AIDS onset
|
ZA938243B
(en)
|
1992-11-12 |
1995-05-04 |
Hybritech Inc |
Altered affinity polypeptides of metal chelate binding antibodies
|
US6010913A
(en)
*
|
1992-12-14 |
2000-01-04 |
N.V. Innogenetics S.A. |
Isolated human tau peptide
|
US5955317A
(en)
|
1993-01-25 |
1999-09-21 |
Takeda Chemical Industries, Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
EP1308461A3
(fr)
|
1993-01-25 |
2004-02-11 |
Takeda Chemical Industries, Ltd. |
Anticorps contre des bèta-amyloides ou leurs dérivés, et leurs utilisations
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
CA2115900A1
(fr)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Cribles pharmaceutiques et anticorps
|
US5840294A
(en)
|
1993-03-29 |
1998-11-24 |
Queen's University At Kingston |
Method for treating amyloidosis
|
PT735893E
(pt)
|
1993-09-14 |
2009-03-06 |
Pharmexa Inc |
Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária
|
ES2173130T3
(es)
|
1993-10-20 |
2002-10-16 |
Univ Duke |
Metodo de fijacion de material al peptido beta-amiloide.
|
US5565352A
(en)
|
1993-11-24 |
1996-10-15 |
Arch Development Corporation |
Deubiquitinating enzyme: compositions and methods
|
JPH09506262A
(ja)
|
1993-12-08 |
1997-06-24 |
ジェンザイム・コーポレイション |
特異的抗体の製造方法
|
AU1397495A
(en)
|
1993-12-13 |
1995-07-03 |
Uab Research Foundation, The |
Diagnostic tests and reagents for detecting risk of alzheimer's disease and stroke
|
US6251395B1
(en)
*
|
1993-12-23 |
2001-06-26 |
W. Michael Gallatin |
Methods of inhibiting inflammation at the site of a central nervous system injury with alphaD-specific antibodies
|
US6620915B2
(en)
|
1993-12-23 |
2003-09-16 |
Icos Corporation |
Monoclonal antibodies specific for integrin α-d subunit
|
US6432404B1
(en)
|
1993-12-23 |
2002-08-13 |
Icos Corporation |
Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies
|
JPH07209295A
(ja)
|
1994-01-10 |
1995-08-11 |
Nikken Chem Co Ltd |
抗体及び酵素標識抗原並びにこれらを用いる酵素免疫測定法及び測定用キット
|
JPH07209296A
(ja)
|
1994-01-10 |
1995-08-11 |
Nikken Chem Co Ltd |
抗原及び酵素標識抗体並びにこれらを用いる酵素免疫測定法及び測定用キット
|
US5877399A
(en)
|
1994-01-27 |
1999-03-02 |
Johns Hopkins University |
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
|
DK1231268T3
(da)
|
1994-01-31 |
2005-11-21 |
Univ Boston |
Polyklonale antistofbiblioteker
|
JPH07238096A
(ja)
|
1994-02-25 |
1995-09-12 |
S R L:Kk |
抗ポリユビキチン・モノクローナル抗体およびポリユビキチンの測定方法
|
JPH07245700A
(ja)
|
1994-03-04 |
1995-09-19 |
Minolta Co Ltd |
デジタル複写機
|
US7473423B2
(en)
|
1994-04-29 |
2009-01-06 |
Mayo Foundation For Medical Education And Research |
Human IgM antibodies, and diagnostic and therapeutic uses thereof particularly in the central nervous system
|
JPH07309900A
(ja)
|
1994-05-20 |
1995-11-28 |
Idemitsu Kosan Co Ltd |
抗ヒトプロカテプシンbモノクローナル抗体、それを産生するハイブリドーマ及びそれを用いたヒトプロカテプシンb又はヒトカテプシンbの測定方法
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
JP3388897B2
(ja)
|
1994-08-31 |
2003-03-24 |
三菱重工業株式会社 |
枚葉印刷機の排紙部
|
US6018021A
(en)
*
|
1994-10-19 |
2000-01-25 |
The Research Foundation Of State University Of New York |
Human transaldolase: an autoantigen with a function in metabolism
|
US6114133A
(en)
|
1994-11-14 |
2000-09-05 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
|
WO1996020698A2
(fr)
|
1995-01-05 |
1996-07-11 |
The Board Of Regents Acting For And On Behalf Of The University Of Michigan |
Nanoparticules a modification de surface et leurs procedes de fabrication et d'utilisation
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
US5505576A
(en)
|
1995-03-09 |
1996-04-09 |
Crane Carrier Company |
Side loader for curbside refuse container
|
JP3663228B2
(ja)
|
1995-03-14 |
2005-06-22 |
株式会社医学生物学研究所 |
ニューロプシンに対する抗体
|
ATE218583T1
(de)
|
1995-03-14 |
2002-06-15 |
Praecis Pharm Inc |
Verbindungen mit aggregations-modulierenden wirkung auf das amyloid protein
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
US6019968A
(en)
*
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
US5705330A
(en)
*
|
1995-04-14 |
1998-01-06 |
Abbott Laboratories |
Chemiluminescent immunoassay for antibody detection
|
JPH11503914A
(ja)
|
1995-04-21 |
1999-04-06 |
セル ジェネシス,インコーポレイテッド |
大ゲノムdna欠失の生成
|
CA2219361C
(fr)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Anticorps humains derives d'une xenosouris immunisee
|
CA2219486A1
(fr)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Anticorps humains derives de xeno-souris immunisees
|
US5712158A
(en)
|
1995-06-06 |
1998-01-27 |
Warner-Lambert Company |
Cell line for the rapid expression of functional calcium channels
|
US6717031B2
(en)
*
|
1995-06-07 |
2004-04-06 |
Kate Dora Games |
Method for selecting a transgenic mouse model of alzheimer's disease
|
AU6255096A
(en)
|
1995-06-07 |
1996-12-30 |
Mount Sinai School Of Medicine Of The City University Of New York, The |
Pegylated modified proteins
|
JP3767755B2
(ja)
|
1995-06-23 |
2006-04-19 |
エーザイ株式会社 |
抗jcウイルス抗体
|
US6127977A
(en)
|
1996-11-08 |
2000-10-03 |
Cohen; Nathan |
Microstrip patch antenna with fractal structure
|
PT859841E
(pt)
|
1995-08-18 |
2002-11-29 |
Morphosys Ag |
Bibliotecas de proteinas/ (poli) peptidos
|
JP2000507912A
(ja)
|
1995-08-31 |
2000-06-27 |
アルカームズ コントロールド セラピューティックス,インコーポレイテッド |
作用剤の徐放性組成物
|
EP0852011B1
(fr)
|
1995-09-14 |
2004-03-31 |
The Regents of the University of California |
ANTICORPS SPECIFIQUE DU PrP?Sc NATIF
|
FR2740454B1
(fr)
|
1995-10-26 |
1997-11-21 |
Rhone Poulenc Rorer Sa |
Peptides capables d'inhiber l'endocytose de l'app et sequences nucleotidiques correspondantes
|
AUPN649395A0
(en)
|
1995-11-10 |
1995-12-07 |
Ramsay Health Care Pty Ltd |
A method for diagnosing alzheimer's disease
|
FR2741881B1
(fr)
|
1995-12-01 |
1999-07-30 |
Centre Nat Rech Scient |
Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
|
KR19980702156A
(ko)
|
1995-12-12 |
1998-07-15 |
히라따 다다시 |
신규 dna, 신규 폴리펩티드 및 신규 항체
|
JPH09178743A
(ja)
|
1995-12-27 |
1997-07-11 |
Oriental Yeast Co Ltd |
可溶性appの定量法
|
ES2176523T3
(es)
|
1996-01-19 |
2002-12-01 |
Res Corp Technologies Inc |
Procedimiento para la deteccion de la enfermedad de alzheimer.
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
ATE364627T1
(de)
|
1996-01-30 |
2007-07-15 |
Scripps Research Inst |
G-protein gekoppelter rezeptor mit vergrösserter, extrazellulärer domäne
|
TR199801532T2
(xx)
|
1996-02-09 |
1998-11-23 |
Basf Aktiengesellschaft |
�nsan TNFalfa 's�n� ba�layan insan antikorlar�.
|
EP0885002B1
(fr)
|
1996-03-04 |
2011-05-11 |
The Penn State Research Foundation |
Materiaux et procedes permettant d'accroitre la penetration intracellulaire
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US6699658B1
(en)
*
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
US6300065B1
(en)
|
1996-05-31 |
2001-10-09 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
WO1997046678A1
(fr)
|
1996-06-06 |
1997-12-11 |
Bayer Corporation |
Acides nucleiques et polypeptides apparentes a la preseniline
|
WO1999009150A1
(fr)
|
1996-08-15 |
1999-02-25 |
Bayer Corporation |
Methode permettant d'introduire des modifications dans un gene
|
CA2183901A1
(fr)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Cibles pour le traitement et le diagnostic de la maladie d'alzheimer et du syndrome de down chez les humains
|
US7521531B2
(en)
|
1996-08-28 |
2009-04-21 |
Immunomedics, Inc. |
Methods for the purification of stable radioiodine conjugates
|
JPH1075781A
(ja)
|
1996-08-30 |
1998-03-24 |
Sumitomo Electric Ind Ltd |
ヒトプロテアソームサブユニットp58蛋白質及びそれに特異的な抗体
|
EP0834561A1
(fr)
|
1996-09-27 |
1998-04-08 |
Rijksuniversiteit te Leiden |
Gène associé avec la migraine dans l'humain
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
WO1998022120A1
(fr)
|
1996-11-19 |
1998-05-28 |
The Wistar Institute Of Anatomy & Biology |
Reactifs pour traiter et diagnostiquer la maladie d'alzheimer
|
EP2314625B1
(fr)
|
1996-12-03 |
2014-05-07 |
Amgen Fremont Inc. |
Mammifères transgèniques obtenus par génie génétique contenant des loci des immunoglobulines humaines qui comprennent plusieurs régions de VH et de Vkappa, et anticorps aussi obtenus
|
US5919687A
(en)
|
1996-12-24 |
1999-07-06 |
John Hopkins University |
Recombinant N-SMases and nucleic acids encoding same
|
DE69732306T2
(de)
|
1997-01-16 |
2006-01-12 |
Massachusetts Institute Of Technology, Cambridge |
Zubereitung von partikelhaltigen arzneimitteln zur inhalation
|
ATE332368T1
(de)
|
1997-01-21 |
2006-07-15 |
Gen Hospital Corp |
Selektion von proteinen mittels rns-protein fusionen
|
JPH10210982A
(ja)
|
1997-01-31 |
1998-08-11 |
Fuji Yakuhin Kogyo Kk |
新規なタンパク質
|
US20030068316A1
(en)
*
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
US6218506B1
(en)
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
US6413940B1
(en)
|
1997-02-07 |
2002-07-02 |
Nymox Corporation |
Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis of DMS
|
US7226730B1
(en)
|
1997-02-26 |
2007-06-05 |
The General Hospital Corporation |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease
|
US7045531B1
(en)
|
1997-03-11 |
2006-05-16 |
The General Hospital Corporation |
Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
|
KR100839689B1
(ko)
|
1997-03-17 |
2008-06-18 |
비티지 인터내셔널 리미티드 |
치료용 조성물
|
JP2002514919A
(ja)
|
1997-04-04 |
2002-05-21 |
バイオサイト ダイアグノスティックス,インコーポレイテッド |
多価ライブラリーおよびポリクローナルライブラリー
|
US20020086847A1
(en)
|
1997-04-09 |
2002-07-04 |
Mindset Biopharmaceuticals (Usa) |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
AU7171098A
(en)
|
1997-05-01 |
1998-11-24 |
Board Of Regents, The University Of Texas System |
Directed evolution of enzymes and antibodies
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
ATE370232T1
(de)
|
1997-05-15 |
2007-09-15 |
Genentech Inc |
Anti-apo-2 antikörper
|
EP0998556B1
(fr)
|
1997-07-21 |
2005-06-15 |
Arpi Matossian-Rogers |
Diagnostique et traitement de maladies utilisant des ligands, notammemt des anticorps, a reactivite contre le recepteur vbeta des cellules t et esrp1
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
US7923216B2
(en)
|
1997-08-14 |
2011-04-12 |
Institut Pasteur |
In vivo modulation of neuronal transport
|
ATE352558T1
(de)
|
1997-08-14 |
2007-02-15 |
Pasteur Institut |
Hybdride tetanustoxinproteine die rückwirkend und transsynatisch ins zns migrieren
|
CA2302317A1
(fr)
|
1997-08-26 |
1999-03-04 |
Gliatech, Inc. |
Procede d'inhibition d'activation de complement par la voie alterne
|
US6666935B1
(en)
|
1997-09-09 |
2003-12-23 |
The Regents Of The University Of California |
Sol-gel manufactured energetic materials
|
FR2768346B1
(fr)
|
1997-09-15 |
2002-04-19 |
Fond Jean Dausset Ceph |
Compose assurant l'inhibition de la preseniline 1 pour la preparation d'un medicament et agent de diagnostic
|
US20040185039A1
(en)
|
2002-08-30 |
2004-09-23 |
Heinz Kohler |
Therapeutic applications of noncovalent dimerizing antibodies
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
AU1197599A
(en)
|
1997-10-24 |
1999-05-17 |
Cornel Research Foundation, Inc. |
Detection of neurodegenerative diseases
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US6710226B1
(en)
*
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
US7179892B2
(en)
*
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US6905686B1
(en)
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
DE69831971T2
(de)
|
1997-12-03 |
2006-07-06 |
Neuralab Ltd., Flatts |
Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
|
AU1507499A
(en)
|
1997-12-15 |
1999-07-05 |
Kyowa Hakko Kogyo Co. Ltd. |
Human nap1 protein
|
US6730778B2
(en)
|
1997-12-19 |
2004-05-04 |
Pharmacia And Upjohn Company |
Human sel-10 polypeptides and polynucleotides that encode them
|
US6436989B1
(en)
|
1997-12-24 |
2002-08-20 |
Vertex Pharmaceuticals, Incorporated |
Prodrugs of aspartyl protease inhibitors
|
US7189703B2
(en)
*
|
1998-01-09 |
2007-03-13 |
Intracell, Llc |
Treatment and diagnosis of alzheimer's disease
|
NZ568553A
(en)
|
1998-02-11 |
2010-02-26 |
Bellus Health Int Ltd |
Treatment of inflammation, AB-induced cell toxicity, neuronal cell death or neuronal loss in subjects suffering from AlzheimerÆs disease
|
JP2002505097A
(ja)
|
1998-03-03 |
2002-02-19 |
アブジェニックス インク. |
治療薬としてのcd147結合分子
|
US6323218B1
(en)
|
1998-03-11 |
2001-11-27 |
The General Hospital Corporation |
Agents for use in the treatment of Alzheimer's disease
|
US20050112543A1
(en)
|
1998-03-11 |
2005-05-26 |
The General Hospital Corporation |
Method of screening for drugs useful in treating Alzheimer's disease
|
US20050059591A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
ATE458007T1
(de)
|
1998-04-20 |
2010-03-15 |
Glycart Biotechnology Ag |
Glykosylierungs-engineering von antikörpern zur verbesserung der antikörperabhängigen zellvermittelten zytotoxizität
|
US6913756B1
(en)
|
1998-04-29 |
2005-07-05 |
The Uab Research Foundation |
Monoclonal antibodies specific for anthrax and peptides derived from the antibodies thereof
|
WO1999058157A1
(fr)
|
1998-05-08 |
1999-11-18 |
Cramer Donald V |
Procede d'inhibition de rejet induit par anticorps de tissus heterologues
|
NO314086B1
(no)
|
1998-05-08 |
2003-01-27 |
Gemvax As |
Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
|
IL139688A0
(en)
|
1998-05-15 |
2002-02-10 |
Neurochem Inc |
Use of amyloid inhibitors for modulating neuronal cell death
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
PT1083889E
(pt)
|
1998-06-01 |
2004-04-30 |
Ortho Mcneil Pharm Inc |
Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
|
JP2000050885A
(ja)
|
1998-06-02 |
2000-02-22 |
Fuji Chemical Industries Ltd |
カテプシンに対する抗体およびそれらの利用
|
CA2336139C
(fr)
|
1998-06-24 |
2008-10-14 |
Advanced Inhalation Research, Inc. |
Grandes particules poreuses emises par un inhalateur
|
AU755340B2
(en)
|
1998-07-02 |
2002-12-12 |
Fuso Pharmaceutical Industries, Ltd. |
Serine protease-specific monoclonal antibody and utilization thereof
|
JP2002522063A
(ja)
|
1998-08-17 |
2002-07-23 |
アブジェニックス インコーポレイテッド |
増加した血清半減期を有する改変された分子の生成
|
US20030109672A1
(en)
|
1998-09-01 |
2003-06-12 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
BR9913850A
(pt)
|
1998-09-17 |
2001-10-23 |
Otsuka Pharma Co Ltd |
Gene ly6h
|
US7083950B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
AU5999199A
(en)
|
1998-09-29 |
2000-04-17 |
Kyowa Hakko Kogyo Co. Ltd. |
Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
JP2002531815A
(ja)
|
1998-12-02 |
2002-09-24 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
オキシダント・ストレス症候群および疾病における脂質の過酸化のレベルを決定する方法および組成物
|
EP1731913A3
(fr)
|
1998-12-02 |
2007-01-17 |
The Trustees Of The University Of Pennsylvania |
Procédés et compositions permettant de déterminer la peroxydation des lipides dans des syndromes et maladies liés au stress du aux oxydants
|
JP4634614B2
(ja)
|
1998-12-14 |
2011-02-16 |
ユニバーシティー オブ マイアミ |
結合組織成長因子(ctgf)断片とそれを用いた方法および使用
|
EP2112166B1
(fr)
|
1998-12-23 |
2018-11-21 |
Pfizer Inc. |
Anticorps monoclonaux humaines pour ctla-4
|
DE19902550A1
(de)
|
1999-01-22 |
2000-07-27 |
Memorec Medical Molecular Rese |
Aspartatprotease
|
US20030185826A1
(en)
|
1999-02-24 |
2003-10-02 |
Tobinick Edward L. |
Cytokine antagonists for the treatment of localized disorders
|
CA2669512A1
(fr)
|
1999-03-25 |
2000-09-28 |
Abbott Gmbh & Co. Kg |
Anticorps humains de liaison de l'il-12 humaine et methodes de production connexes
|
FR2791263B1
(fr)
|
1999-03-26 |
2001-04-27 |
Halina Zofia Malina |
Preparations des medicaments bases sur une reponse immunitaire contre l'accumulation de proteines modifiees par l'acide xanthurenique
|
EP3031917A1
(fr)
|
1999-04-09 |
2016-06-15 |
Kyowa Hakko Kirin Co., Ltd. |
Procédé de contrôle de l'activité d'une molécule immunologiquement fonctionnelle
|
US7527787B2
(en)
|
2005-10-19 |
2009-05-05 |
Ibc Pharmaceuticals, Inc. |
Multivalent immunoglobulin-based bioactive assemblies
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
PE20010212A1
(es)
|
1999-06-01 |
2001-02-22 |
Neuralab Ltd |
Composiciones del peptido a-beta y procesos para producir las mismas
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
US20030082554A1
(en)
|
1999-06-03 |
2003-05-01 |
Curagen Corporation |
Novel nucleic acid sequences encoding human cell adhesion molecule protein-like polypeptides
|
JP2000354487A
(ja)
|
1999-06-15 |
2000-12-26 |
Takashi Muramatsu |
ミッドカイン受容体
|
US20020002270A1
(en)
|
1999-06-16 |
2002-01-03 |
Raymond P. Zinkowski |
Purified antigen for alzheimer's disease, and methods of obtaining and using same
|
AU780474B2
(en)
|
1999-06-16 |
2005-03-24 |
Boston Biomedical Research Institute Incorporated |
Immunological control of beta-amyloid levels in vivo
|
AU6524500A
(en)
|
1999-08-04 |
2001-03-05 |
Northwestern University |
Amyloid beta protein (globular assembly and uses thereof)
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
KR100996759B1
(ko)
|
1999-08-24 |
2010-11-25 |
메다렉스, 인코포레이티드 |
인간 씨티엘에이-4 항체 및 그의 용도
|
WO2001016364A2
(fr)
|
1999-09-01 |
2001-03-08 |
Evotec Neurosciences Gmbh |
Procede de diagnostic ou de pronostic de la degenerescence maculaire liee a l'age
|
US20040013647A1
(en)
*
|
1999-09-03 |
2004-01-22 |
Ramot At Tel-Aviv University Ltd. |
Methods and compositions for treating a plaque-forming disease
|
WO2001018169A2
(fr)
|
1999-09-03 |
2001-03-15 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Agents et compositions et procedes utilisant lesdits agents et lesdites compositions pour le diagnostic et/ou le traitement ou la prevention des maladies formant des plaques.
|
US6294171B2
(en)
|
1999-09-14 |
2001-09-25 |
Milkhaus Laboratory, Inc. |
Methods for treating disease states comprising administration of low levels of antibodies
|
JP2001122900A
(ja)
|
1999-10-21 |
2001-05-08 |
Yasukazu Tanuma |
抗−DNaseγ抗体並びにその製造及び使用
|
AU1456101A
(en)
|
1999-11-03 |
2001-05-14 |
Maxygen, Inc. |
Antibody diversity generation
|
NZ540564A
(en)
|
1999-11-29 |
2007-04-27 |
Neurochem Int Ltd |
Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases
|
US20070135337A2
(en)
*
|
1999-11-29 |
2007-06-14 |
Neurochem (International) Limited |
Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
EP1752472A3
(fr)
|
1999-12-08 |
2007-04-25 |
Intellect Neurosciences, Inc. |
Peptides amyloides beta chimériques
|
ES2275570T3
(es)
|
1999-12-08 |
2007-06-16 |
Intellect Neurosciences, Inc. |
Peptidos amiloides beta quimericos.
|
JP2001231578A
(ja)
|
1999-12-09 |
2001-08-28 |
Kyowa Hakko Kogyo Co Ltd |
Il−1ファミリーに属する蛋白質
|
KR20080003945A
(ko)
|
1999-12-23 |
2008-01-08 |
뉴로겜 인터내셔널 리미티드 |
대뇌 아밀로이드 혈관병증을 조절하는 화합물 및 방법
|
US20030077757A1
(en)
*
|
2000-01-11 |
2003-04-24 |
Andrews William H. |
Method of treating aging-related disorders
|
EP1252729A1
(fr)
|
2000-01-17 |
2002-10-30 |
Avanex Corporation |
Attenuateur integre a un modulateur et module d'emission pour systeme mrl utilisant cet attenuateur
|
US6806254B2
(en)
|
2000-02-03 |
2004-10-19 |
Nuvelo, Inc. |
Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides
|
US20020182660A1
(en)
|
2000-02-18 |
2002-12-05 |
Fong Kei-Lai L. |
N- and C-terminus specific immunoassays for full length beta-amyloid peptide-Abeta(1-40), Abeta(1-39), Abeta(1-40), Abeta(1-42) , and Abeta(1-43)
|
MXPA02007796A
(es)
|
2000-02-21 |
2003-12-08 |
Pharmexa As |
Metodo novedoso para la disminucion de cuerpos amiloides.
|
WO2001062284A2
(fr)
|
2000-02-21 |
2001-08-30 |
Pharmexa A/S |
Nouvelle methode de regulation negative d'amyloide
|
PL210157B1
(pl)
*
|
2000-02-24 |
2011-12-30 |
Lilly Co Eli |
Humanizowane przeciwciało lub jego fragment, kwas polinukleinowy, wektor ekspresyjny do ekspresji przeciwciała lub jego fragmentu, komórka transfekowana wektorem ekspresyjnym, kompozycja farmaceutyczna i zastosowanie humanizowanego przeciwciała lub jego fragmentu do leczenia choroby Alzheimera
|
EP1130032A1
(fr)
|
2000-02-28 |
2001-09-05 |
Gesellschaft für biotechnologische Forschung mbH (GBF) |
Anticorps monochaines reconnaissant le récepteur humain de type 2 du facteur de croissance vasculaire endothéliale (VEGFR-2/KDR)
|
GB0006398D0
(en)
|
2000-03-16 |
2000-05-03 |
Novartis Ag |
Organic compounds
|
WO2001071351A1
(fr)
*
|
2000-03-22 |
2001-09-27 |
The General Hospital Corporation |
Procede destine au traitement des maladies neurodegeneratives
|
WO2001075165A2
(fr)
|
2000-03-30 |
2001-10-11 |
Elan Pharmaceuticals, Inc. |
Marqueurs et methodes de criblage pour maladies neurodegeneratives
|
AU2001249835A1
(en)
*
|
2000-04-03 |
2001-10-15 |
Oxford Glycosciences (Uk) Ltd. |
Diagnosis and treatment of alzheimer's disease
|
US7371365B2
(en)
|
2000-04-04 |
2008-05-13 |
Mayo Foundation For Medical Education And Research |
Methods for detecting parenchymal plaques in vivo
|
AUPQ712000A0
(en)
|
2000-04-27 |
2000-05-18 |
Medvet Science Pty. Ltd. |
Antigenic peptide fragments of VapA protein, and uses thereof
|
US20080009467A1
(en)
*
|
2000-05-01 |
2008-01-10 |
Accera, Inc. |
Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
|
WO2001083525A2
(fr)
|
2000-05-03 |
2001-11-08 |
Amgen Inc. |
Peptides modifies utilises comme agents therapeutiques
|
AU7487301A
(en)
|
2000-05-22 |
2001-12-03 |
Univ New York |
Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
|
NZ523105A
(en)
|
2000-06-22 |
2004-07-30 |
Genentech Inc |
Agonist anti-trk-C monoclonal antibodies
|
JP4252195B2
(ja)
|
2000-06-27 |
2009-04-08 |
新日本無線株式会社 |
高周波線路の変換器
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
AU6882801A
(en)
|
2000-06-28 |
2002-01-08 |
Prana Biotechnology Ltd |
Neurotoxic oligomers
|
US7029872B2
(en)
|
2000-06-28 |
2006-04-18 |
Glycofi, Inc |
Methods for producing modified glycoproteins
|
US6686449B2
(en)
*
|
2000-06-30 |
2004-02-03 |
Pharmacia & Upjohn Company |
Mutant presenilin 1 polypeptides
|
CA2412925A1
(fr)
|
2000-07-06 |
2002-01-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Nouvelle mutation app associee a une pathologie inhabituelle de la maladie d'alzheimer
|
CA2414772C
(fr)
*
|
2000-07-07 |
2011-06-28 |
Jan Naslund |
Prevention et traitement de la maladie d'alzheimer
|
AU2007200047B2
(en)
|
2000-07-07 |
2009-11-26 |
Bioarctic Neuroscience Ab |
Prevention and treatment of Alzheimer's disease
|
US6524819B1
(en)
|
2000-07-11 |
2003-02-25 |
Incyte Genomics, Inc. |
Down syndrome critical region 1-like proteins
|
US20020009445A1
(en)
|
2000-07-12 |
2002-01-24 |
Yansheng Du |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
EP1172378A1
(fr)
|
2000-07-12 |
2002-01-16 |
Richard Dr. Dodel |
Anticorps humains anti-beta-amyloid et leur utilisation pour le traitement de la maladie d'Alzheimer
|
JP2002040023A
(ja)
|
2000-07-28 |
2002-02-06 |
Mitsubishi Chemicals Corp |
アルツハイマー病の検出方法
|
US20070009931A1
(en)
*
|
2000-08-04 |
2007-01-11 |
Kirsch Wolff M |
Negative correlation between IRP-2 and Transferrin receptor expression as a diagnostic of Alzheimer's disease
|
EP1317479B1
(fr)
|
2000-09-06 |
2009-09-02 |
Aventis Pharma S.A. |
Procedes et compositions relatifs a des maladies associees a l'amyloide
|
GB0024446D0
(en)
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Protein
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
US6962793B2
(en)
|
2000-10-27 |
2005-11-08 |
Mount Sinai Hospital |
Methods for detecting Alzheimers disease
|
EP1363939A2
(fr)
|
2000-11-01 |
2003-11-26 |
Insight Biotechnology Limited |
Peptides destines a une utilisation dans le traitement de la maladie d'alzheimer
|
WO2002094870A2
(fr)
|
2000-11-02 |
2002-11-28 |
Curagen Corporation |
Proteines et acides nucleiques codant pour ces proteines
|
DE10055703A1
(de)
|
2000-11-02 |
2002-05-08 |
Peter F Pascoe |
Verhinderung der Zellzerstörung und Beseitigung sklrotischer Amyloide verursacht durch organspezifische Antikörperaggregate
|
EP1341548A4
(fr)
|
2000-11-03 |
2006-06-14 |
Massachusetts Inst Technology |
Methodes d'identification de traitements de la neurotoxicite dans la maladie d'alzheimer engendree par des peptides $g(b)-amyloides
|
US20060062786A1
(en)
*
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
DK1346041T3
(da)
|
2000-11-27 |
2007-07-02 |
Praecis Pharm Inc |
Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
|
PE20020574A1
(es)
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
GB0100110D0
(en)
|
2001-01-04 |
2001-02-14 |
Univ Leeds |
Modulation of calcium channel activity
|
DE10101430B4
(de)
|
2001-01-13 |
2008-10-02 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Lösliche cyclische Analoga zur Modulation der Amyloidogenese
|
US20020132758A1
(en)
|
2001-01-18 |
2002-09-19 |
Shell John W. |
Method for identifying compounds to treat medical pathologies associated with molecular crystallization
|
US7320793B2
(en)
*
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
US20040191264A1
(en)
|
2001-02-19 |
2004-09-30 |
Nielsen Klaus Gregorius |
Synthetic vaccine agents
|
CA2439120C
(fr)
|
2001-02-23 |
2011-07-05 |
Genentech, Inc. |
Polymeres erodables a injecter
|
JP4659236B2
(ja)
|
2001-03-01 |
2011-03-30 |
大塚製薬株式会社 |
細胞傷害活性の測定法
|
FR2822238B1
(fr)
*
|
2001-03-16 |
2003-08-29 |
Gemac |
Methode et trousse pour le suivi des maladies neurodegeneratives
|
US6815175B2
(en)
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
DE10117281A1
(de)
|
2001-04-06 |
2002-10-24 |
Inst Molekulare Biotechnologie |
Peptid zur Diagnose und Therapie der Alzheimer-Demenz
|
WO2002085922A2
(fr)
|
2001-04-23 |
2002-10-31 |
Curagen Corporation |
Proteines et acides nucleiques codant pour celles-ci
|
US6451547B1
(en)
|
2001-04-25 |
2002-09-17 |
Syn X Pharma |
Process for differential diagnosis of Alzheimer's dementia and device therefor
|
AU2002257162A1
(en)
|
2001-04-30 |
2002-11-11 |
Eli Lilly And Company |
Humanized antibodies
|
ATE420114T1
(de)
*
|
2001-04-30 |
2009-01-15 |
Lilly Co Eli |
Humanisierte antikörper die das beta-amyloid peptid erkennen& x9;
|
EP1395275B1
(fr)
|
2001-05-22 |
2008-11-12 |
Merck & Co., Inc. |
Substrat de beta-secretase et ses utilisations
|
US7196163B2
(en)
*
|
2001-05-22 |
2007-03-27 |
Merk & Co., Inc. |
Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
ATE277952T1
(de)
|
2001-06-12 |
2004-10-15 |
Wiltfang Jens |
Monoklonaler antikörper, mbab 1e8, welcher für die zwei ersten n-terminalen aminosäuren von amyloid-beta-peptiden spezifisch ist und dessen verwendung zum nachweis von amyloid-beta peptiden und/oder sappa
|
US7595378B2
(en)
|
2001-06-13 |
2009-09-29 |
Genmab A/S |
Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
|
IL159225A0
(en)
|
2001-06-13 |
2004-06-01 |
Genmab As |
Human monoclonal antibodies to epidermal growth factor receptor (egfr)
|
US7094884B2
(en)
|
2001-06-22 |
2006-08-22 |
Roche Diagnostics Corporation |
Soluble complexes of amylod β peptide and peptidyl prolyl isomerase chaperone and methods of making and using them
|
US20020197258A1
(en)
|
2001-06-22 |
2002-12-26 |
Ghanbari Hossein A. |
Compositions and methods for preventing protein aggregation in neurodegenerative diseases
|
CN1396183A
(zh)
|
2001-07-13 |
2003-02-12 |
张小如 |
降低脑内与老年痴呆有关的淀粉样变纤维的融合人抗体
|
WO2003008626A2
(fr)
|
2001-07-20 |
2003-01-30 |
Oregon Health And Science University |
Nouveaux acides nucleiques humains codant pour une pantothenate kinase et procedes d'utilisation
|
EP1420032B2
(fr)
|
2001-08-03 |
2015-12-16 |
Medical & Biological Laboratories Co., Ltd. |
Anticorps reconnaissant la proteine beta-amyloide liee au ganglioside gm1, et adn codant l'anticorps
|
JP4320694B2
(ja)
|
2001-08-08 |
2009-08-26 |
株式会社オーク製作所 |
多重露光描画装置および多重露光式描画方法
|
US7589168B2
(en)
|
2001-08-10 |
2009-09-15 |
Roskamp Research Llc |
Inhibition of angiogenesis by A-β peptides
|
EP1944040B1
(fr)
|
2001-08-17 |
2012-08-01 |
Washington University |
Procédé d'analyse pour la maladie d'Alzheimer
|
US20040241164A1
(en)
|
2001-08-17 |
2004-12-02 |
Bales Kelly Renee |
Use of antibodies having high affinity for soluble ab to treat conditions and diseases related to ass
|
CA2451998A1
(fr)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
Anticorps anti-$g(a)$g(b)
|
AU2002324468A1
(en)
|
2001-08-17 |
2003-03-03 |
Eli Lilly And Company |
Rapid improvement of cognition in conditions related to abeta
|
ES2295401T3
(es)
|
2001-08-17 |
2008-04-16 |
Washington University |
Metodo de ensayo para la enfermedad de alzheimer.
|
MY144532A
(en)
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
US20030082191A1
(en)
|
2001-08-29 |
2003-05-01 |
Poduslo Joseph F. |
Treatment for central nervous system disorders
|
CA2462113C
(fr)
|
2001-10-01 |
2013-01-29 |
Dyax Corp. |
Vecteurs d'affichage eukaryotes multichaine et leurs utilisations
|
JP2003284574A
(ja)
|
2001-10-03 |
2003-10-07 |
Pfizer Prod Inc |
核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用
|
EP1463527A4
(fr)
|
2001-10-04 |
2005-05-11 |
Protein Therapeutics Inc |
Utilisation de gammaglobuline pour le traitement de maladies d'origine immunologique
|
DE60225821T2
(de)
|
2001-10-04 |
2009-04-30 |
Immuno-Biological Laboratories Co., Ltd., Takasaki |
Reagens zum Nachweis eines Risikofaktors der Alzheimer-Krankheit, Nachweiskit dafür und Verfahren zum Nachweis eines Risikofaktors der Alzheimer-Krankheit unter ihrer Verwendung
|
GB0124317D0
(en)
*
|
2001-10-10 |
2001-11-28 |
Celltech R&D Ltd |
Biological products
|
EP1443961B1
(fr)
|
2001-10-25 |
2009-05-06 |
Genentech, Inc. |
Compositions de glycoproteine
|
US7060270B2
(en)
|
2001-11-02 |
2006-06-13 |
Diagenics International Corporation |
Methods and compositions of monoclonal antibodies specific for beta-amyloid proteins
|
CA2466841A1
(fr)
|
2001-11-21 |
2003-06-05 |
New York University |
Polypeptides immunogenes synthetiques ne formant pas de depots et peptides homologues destines a des repetitions amyloide $g(b), proteine prion, amyline, $g(a)-synucleine, ou polyglutamine pour induction d'une reponse immunitaire a ceux-ci
|
US7179606B2
(en)
*
|
2001-11-23 |
2007-02-20 |
Syn X Pharma, Inc. |
IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
|
US7026129B2
(en)
|
2001-11-23 |
2006-04-11 |
Syn X Pharma, Inc. |
IG lambda biopolymer markers predictive of Alzheimers disease
|
DE10158180A1
(de)
*
|
2001-11-28 |
2003-09-11 |
Biovision Ag |
Verfahren zum Nachweis von Morbus Alzheimer und zur Unterscheidung von Morbus Alzheimer gegenüber anderen demenziellen Erkrankungen, zugehörige Peptide und deren Verwendung
|
EP1451226A1
(fr)
|
2001-11-30 |
2004-09-01 |
Crucell Holland B.V. |
Conjugue de ciblage de cellule de presentation de l'antigene, cellule de presentation de l'antigene mise en contact avec ledit conjugue, leur utilisation pour la vaccination ou en tant que medicament et leurs procedes de production ou de generation
|
JP2005521645A
(ja)
|
2001-12-04 |
2005-07-21 |
ベン グリオン ユニバーシティ オブ ザ ネジェブ リサーチ アンド ディベラップメント オーソリティ |
器官特異的薬物ターゲティング用両親媒性化合物及び小胞/リポソーム
|
AU2002366355A1
(en)
|
2001-12-17 |
2003-06-30 |
New York State Office Of Mental Health |
SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
|
US20070128191A1
(en)
|
2001-12-26 |
2007-06-07 |
Universidad De Zaragoza |
Polyclonal antibodies, preparation method thereof and use of same
|
WO2005000193A2
(fr)
*
|
2003-06-30 |
2005-01-06 |
Tel Aviv University Future Technology Development L.P. |
Peptides, anticorps diriges contre les maladies associees a l'amyloide et procedes d'utilisation pour le diagnostic et le traitement de ces maladies
|
US7781396B2
(en)
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20050153381A1
(en)
|
2002-02-14 |
2005-07-14 |
Marusich Michael F. |
Immunocapture of mitochondrial protein complexes
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
DE10208812A1
(de)
|
2002-03-01 |
2003-09-11 |
Basf Plant Science Gmbh |
Verfahren zur Herstellung von ungesättigten Fettsäuren
|
AU2003213718A1
(en)
|
2002-03-01 |
2003-09-16 |
Szu-Yi Chou |
Method of producing antigens
|
US20040018557A1
(en)
|
2002-03-01 |
2004-01-29 |
Immunomedics, Inc. |
Bispecific antibody point mutations for enhancing rate of clearance
|
EP2292247A3
(fr)
|
2002-03-05 |
2011-10-05 |
Ramot at Tel Aviv University Ltd. |
Composition immunisante et procédé permettant d'induire une réponse immunitaire contre le site de clivage de la bêta-sécrétase
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
CN1305905C
(zh)
|
2002-03-22 |
2007-03-21 |
Aprogen株式会社 |
人源化抗体及其制备方法
|
US20030190689A1
(en)
|
2002-04-05 |
2003-10-09 |
Cell Signaling Technology,Inc. |
Molecular profiling of disease and therapeutic response using phospho-specific antibodies
|
US7122374B1
(en)
|
2002-04-09 |
2006-10-17 |
Takaomi Saido |
Amyloid beta-protein 3(pE)-42 antibodies and uses thereof
|
US20070134247A9
(en)
|
2002-04-12 |
2007-06-14 |
Ramot At Tel Aviv University Ltd. |
Prevention of brain inflammation as a result of induced autoimmune response
|
PL209696B1
(pl)
|
2002-04-19 |
2011-10-31 |
Univ Toronto |
Peptyd, kompozycja peptydowa, kompozycja immunogenna, zastosowania kompozycji immunogennej oraz sposób określania czy związek stanowi inhbitor odkładania się i tworzenia włókienek amyloidu
|
AU2003224120A1
(en)
|
2002-04-24 |
2003-11-10 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases
|
DE60325717D1
(de)
|
2002-04-25 |
2009-02-26 |
Lilly Co Eli |
Verfahren zur behandlung von angststörungen bei älteren personen
|
US20060257420A1
(en)
|
2002-04-26 |
2006-11-16 |
Cel-Sci Corporation |
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions
|
DE10221052A1
(de)
|
2002-05-10 |
2003-12-04 |
Transmit Technologietransfer |
Wirkstoffe zu Therapie, Diagnostik und Prophylaxe von Erkrankungen, bei denen abnorme Proteinstrukturen auftreten
|
WO2003100419A1
(fr)
|
2002-05-27 |
2003-12-04 |
Bioceros B.V. |
Procedes d'utilisation de la voie de cd163 pour moduler une reponse immunitaire
|
CA2489341A1
(fr)
|
2002-06-14 |
2003-12-24 |
Brainsgate, Ltd. |
Procedes et systemes de gestion de la maladie d'alzheimer
|
EP1514118A2
(fr)
|
2002-06-20 |
2005-03-16 |
EVOTEC Neurosciences GmbH |
Utilisation, en matiere de diagnostic et de therapie de maladies neurodegeneratives, de la proteine 2 (g3bp2) se fixant au domaine sh3 de la proteine activant la ras gtpase
|
AU2003260301A1
(en)
|
2002-06-27 |
2004-01-19 |
Evotec Neurosciences Gmbh |
Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases
|
SI1517921T1
(sl)
|
2002-06-28 |
2006-10-31 |
Domantis Ltd |
Dvojno-specificni ligandi z zvisano serumsko razpolovno dobo
|
DE60323231D1
(de)
|
2002-07-12 |
2008-10-09 |
Axon Neuroscience |
Verkürzte tau proteine
|
CA2493119A1
(fr)
|
2002-07-17 |
2004-01-22 |
Mindset Biopharmaceuticals Usa Inc. |
Peptides et procedes de criblage de vaccins a base de peptides immunogenes contre la maladie d'alzheimer
|
US7666982B2
(en)
|
2002-07-18 |
2010-02-23 |
Masayasu Okochi |
Notch-origin polypeptides and biomarkers and reagents using the same
|
US20040136991A1
(en)
|
2002-07-19 |
2004-07-15 |
Abbott Biotechnology Ltd. |
Treatment of anemia using TNFalpha inhibitors
|
JP4644488B2
(ja)
|
2002-07-19 |
2011-03-02 |
サイトス・バイオテクノロジー・アクチェンゲゼルシャフト |
アミロイドベータ1−6抗原アレイを含むワクチン組成物
|
EP1523499A2
(fr)
|
2002-07-24 |
2005-04-20 |
Innogenetics N.V. |
Fragments du peptide beta-amyloide en tant que cibles pour la vaccination contre la maladie d'alzheimer
|
US7250551B2
(en)
*
|
2002-07-24 |
2007-07-31 |
President And Fellows Of Harvard College |
Transgenic mice expressing inducible human p25
|
SE0202880D0
(sv)
|
2002-07-26 |
2002-09-30 |
Wieslab Ab |
Complement system deficiency assay
|
AU2003259222A1
(en)
|
2002-07-30 |
2004-02-16 |
The Regents Of The University Of California |
Method of diagnosing alzheimer's disease
|
US20040138296A1
(en)
|
2002-08-12 |
2004-07-15 |
Pharmacia Corporation |
Amyloid immunization and Cox-2 inhibitors for the treatment of alzheimer's disease
|
US7252953B2
(en)
|
2002-08-13 |
2007-08-07 |
United States Of America Department Of Veterans Affairs |
Method of detecting and preventing Alzheimer's disease, particularly at prodromal and early stages
|
EP1535930B1
(fr)
|
2002-08-14 |
2010-10-06 |
Mitsubishi Chemical Medience Corporation |
Anticorps specifique de la proteine tau du système nerveux central
|
WO2004018997A2
(fr)
|
2002-08-20 |
2004-03-04 |
Neurogenetics, Inc. |
Techniques et compositions permettant de moduler une amyloide beta
|
AU2003266302A1
(en)
|
2002-08-23 |
2004-03-11 |
Proteosys Ag |
Method for the diagnosis of alzheimer disease
|
AU2003270643A1
(en)
|
2002-09-12 |
2004-04-30 |
The Regents Of The University Of California |
Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
|
US20070010657A1
(en)
*
|
2002-09-13 |
2007-01-11 |
Rainer Klocke |
Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases
|
US7238488B2
(en)
*
|
2002-09-13 |
2007-07-03 |
Grace Maresh |
Therapeutic and diagnostic applications of perlecan domain I splice variants
|
JP2006502188A
(ja)
|
2002-09-17 |
2006-01-19 |
ニューヨーク ユニバーシティ |
年齢関連記憶欠陥(aami)、中程度認識欠陥(mci)、および痴呆を細胞周期インヒビターで処置する方法
|
JP4242128B2
(ja)
|
2002-09-18 |
2009-03-18 |
武田薬品工業株式会社 |
脳アミロイドーシス予防・治療薬のスクリーニング方法
|
WO2004029629A1
(fr)
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
Anticorps monoclonaux beta-amyloide n-11 tronques, compositions, methodes et utilisations
|
US7541440B2
(en)
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
JP2006508072A
(ja)
*
|
2002-10-01 |
2006-03-09 |
ノースウエスタン ユニバーシティ |
アミロイドベータ由来拡散性リガンド(ADDLs)、ADDL代替物、ADDL結合性分子、およびそれらの使用
|
US20070213512A1
(en)
|
2002-10-01 |
2007-09-13 |
Krafft Grant A |
Amyloid beta peptide analogs and assemblies thereof
|
WO2004031241A1
(fr)
|
2002-10-04 |
2004-04-15 |
Techno Network Shikoku Co., Ltd. |
Anticorps monoclonal agissant a l'encontre de la proproteine de type subtilisine convertase pace4 et son utilisation
|
JP2006514824A
(ja)
|
2002-10-09 |
2006-05-18 |
アクティブクス バイオサイエンスィズ インコーポレイテッド |
活性に基づくプローブ,およびその製造および使用方法
|
PL377769A1
(pl)
|
2002-10-09 |
2006-02-20 |
Rinat Neuroscience Corp. |
Sposób leczenia choroby Alzheimera z zastosowaniem przeciwciał skierowanych przeciw peptydowi beta amyloidu i ich kompozycje
|
WO2004038411A2
(fr)
|
2002-10-24 |
2004-05-06 |
Evotec Neurosciences Gmbh |
Utilisations diagnostique et therapeutique d'un gene de l'ensadin-0289 et d'une proteine pour des maladies neurodegeneratives
|
TW200509968A
(en)
|
2002-11-01 |
2005-03-16 |
Elan Pharm Inc |
Prevention and treatment of synucleinopathic disease
|
US20080014194A1
(en)
*
|
2003-10-31 |
2008-01-17 |
Elan Pharmaceuticals, Inc. |
Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
|
FR2846667B1
(fr)
|
2002-11-06 |
2004-12-31 |
Pasteur Institut |
Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
|
WO2004043989A2
(fr)
|
2002-11-07 |
2004-05-27 |
Medarex, Inc. |
Anticorps monoclonaux humains diriges contre l'heparanase
|
AU2003294290A1
(en)
|
2002-11-15 |
2004-06-15 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
|
DE10256900A1
(de)
|
2002-11-29 |
2004-06-24 |
Nemod Immuntherapie Ag |
Tumorspezifische Erkennungsmoleküle
|
CN100450551C
(zh)
|
2002-11-29 |
2009-01-14 |
中国医学科学院基础医学研究所 |
用于治疗和预防阿尔茨海默病的重组腺相关病毒基因疫苗及其用途
|
WO2004050850A2
(fr)
|
2002-12-02 |
2004-06-17 |
Abgenix, Inc. |
Anticorps diriges contre la phospholipase a2 et utilisations
|
AU2003303198A1
(en)
|
2002-12-19 |
2004-07-14 |
New York University |
Method for treating amyloid disease
|
MXPA05006940A
(es)
|
2002-12-24 |
2006-02-22 |
Neurochem Int Ltd |
Formulaciones terapeuticas para el tratamiento de enfermedades relacionadas con beta - amiloide.
|
US20050031651A1
(en)
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
GB0230203D0
(en)
|
2002-12-27 |
2003-02-05 |
Domantis Ltd |
Fc fusion
|
AT413945B
(de)
|
2003-01-14 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff für die alzheimer-krankheit
|
US7662380B2
(en)
|
2003-01-22 |
2010-02-16 |
Takeda Pharmaceutical Company Limited |
ZAQ ligand-1 antibodies and uses thereof
|
ES2729974T3
(es)
|
2003-01-23 |
2019-11-07 |
Ono Pharmaceutical Co |
Anticuerpo específico de PD-1 y CD3 humanas
|
WO2004065569A2
(fr)
|
2003-01-23 |
2004-08-05 |
The Regents Of The University Of California |
Anticorps multifonctionnels
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
CA2513722A1
(fr)
|
2003-02-01 |
2004-08-19 |
Neuralab Limited |
Immunisation active permettant de produire des anticorps contre a-beta soluble
|
EP1608684A2
(fr)
|
2003-02-07 |
2005-12-28 |
Protein Design Labs, Inc. |
Anticorps anti-amphireguline (ar) et leur utilisation dans le traitement du cancer et du psoriasis
|
ATE468886T1
(de)
|
2003-02-10 |
2010-06-15 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
US20040242845A1
(en)
|
2003-02-21 |
2004-12-02 |
Nicolau Yves Claude |
Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
|
DE10307603A1
(de)
|
2003-02-22 |
2004-09-02 |
Rieter Ingolstadt Spinnereimaschinenbau Ag |
Textilmaschine
|
US20060188951A1
(en)
|
2003-02-24 |
2006-08-24 |
In Hee Mook |
Method for measuring the level of anti-beta-amyloid antibody in body fluids and diagnostic kit for alzheimer's disease using same
|
US20040223970A1
(en)
*
|
2003-02-28 |
2004-11-11 |
Daniel Afar |
Antibodies against SLC15A2 and uses thereof
|
EP2177620B1
(fr)
|
2003-03-05 |
2014-11-19 |
Halozyme, Inc. |
Glycoprotéine d'hyaluronidase soluble (sHASEGP), son procédé de préparation, utilisations et compositions pharmaceutiques le comportant
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
US8545830B2
(en)
|
2003-03-24 |
2013-10-01 |
University Of Tennessee Research Foundation |
Multi-functional polymeric materials and their uses
|
EP1615946B1
(fr)
|
2003-03-26 |
2020-05-06 |
Sudhir Paul |
Anticorps proteolytiques et covalents
|
US20050129695A1
(en)
|
2003-03-28 |
2005-06-16 |
Marc Mercken |
Anti-amyloid antibodies, compositions, methods and uses
|
CN1189210C
(zh)
|
2003-03-28 |
2005-02-16 |
万选才 |
Cb与生物活性多肽的偶联物及其医药用途
|
WO2004087733A2
(fr)
|
2003-03-28 |
2004-10-14 |
New York University |
Prevention et traitement du depot d'amyloide dans la maladie d'alzheimer
|
DK1625402T3
(en)
|
2003-04-09 |
2014-03-10 |
Canadian Blood Services |
Detection, characterization and treatment of viral infection, and methods therefor
|
EP1469312A1
(fr)
|
2003-04-18 |
2004-10-20 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Le diagnostic de la maladie d'Alzheimer
|
US20060240485A1
(en)
|
2003-04-24 |
2006-10-26 |
Universitat Zurich |
Method of monitoring immunotherapy
|
CA2524737A1
(fr)
|
2003-05-06 |
2005-02-24 |
Human Genome Sciences, Inc. |
Anticorps se liant de maniere immunospecifique aux recepteurs trail
|
US20040223912A1
(en)
|
2003-05-07 |
2004-11-11 |
Montalto Michael Christopher |
Compositions and methods for non-invasive imaging of soluble beta-amyloid
|
ES2246105B1
(es)
|
2003-05-08 |
2007-03-01 |
Araclon Biotech, S.L. |
Uso de anticuerpos para el tratamiento de enfermedades amiloideas.
|
EP1480041A1
(fr)
|
2003-05-22 |
2004-11-24 |
Innogenetics N.V. |
Méthode de prédiction, diagnostic et diagnostic différential de la maladie d'Alzheimer
|
WO2005018536A2
(fr)
|
2003-05-23 |
2005-03-03 |
Human Genome Sciences, Inc. |
Anticorps agonistes de liaison specifique au recepteur de peptide 1 assimile au glucagon
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
AU2004294893A1
(en)
|
2003-06-06 |
2005-06-16 |
Oncomax Acquisition Corp. |
Antibodies specific for cancer associated antigen SM5-1 and uses thereof
|
US7892751B2
(en)
|
2003-06-09 |
2011-02-22 |
Redox-Reactive Reagents Llc |
Method of detecting or diagnosing of a neurodegenerative disease or condition
|
JP4888876B2
(ja)
|
2003-06-13 |
2012-02-29 |
田平 武 |
アルツハイマー病の治療のための組換えアデノ随伴ウィルスベクター
|
EP1644415B1
(fr)
|
2003-06-23 |
2010-12-01 |
Genetics Institute, LLC |
Anticorps contre l'interleukine-22 et utilisations
|
US20050009110A1
(en)
*
|
2003-07-08 |
2005-01-13 |
Xiao-Jia Chang |
Methods of producing antibodies for diagnostics and therapeutics
|
ATE444946T1
(de)
|
2003-07-15 |
2009-10-15 |
Ono Pharmaceutical Co |
Verzweigte carbonsäureverbindung und deren verwendung
|
US20050123553A1
(en)
|
2003-07-30 |
2005-06-09 |
Alon Monsonego |
Amyloid beta-peptide and methods of use
|
WO2005011599A2
(fr)
|
2003-08-01 |
2005-02-10 |
Northwestern University |
Anticorps specifiques des oligomeres a proteines beta amyloides toxiques
|
EP1651663B1
(fr)
|
2003-08-08 |
2017-05-17 |
Immunomedics, Inc. |
Anticorps bispecifiques pour induire l'apoptose de cellules tumorales et malades
|
JP4239750B2
(ja)
*
|
2003-08-13 |
2009-03-18 |
セイコーエプソン株式会社 |
マイクロレンズ及びマイクロレンズの製造方法、光学装置、光伝送装置、レーザプリンタ用ヘッド、並びにレーザプリンタ
|
WO2005018424A2
(fr)
|
2003-08-18 |
2005-03-03 |
Research Foundation For Mental Hygiene, Inc. |
Anticorps specifiques de la proteine amyloide fibrillaire et procedure permettant de detecter des depots de proteines amyloides fibrillaires
|
AU2004280333A1
(en)
*
|
2003-08-22 |
2005-04-21 |
Medimmune, Llc |
Humanization of antibodies
|
WO2005025616A1
(fr)
|
2003-09-09 |
2005-03-24 |
Takeda Pharmaceutical Company Limited |
Utilisation d'un anticorps
|
US20070110750A1
(en)
|
2003-09-12 |
2007-05-17 |
The Regents Of The University Of California |
Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
|
EP1516930A1
(fr)
|
2003-09-16 |
2005-03-23 |
Georg-August Universität Göttingen |
Modèle cellulaire des tauopathies pour identifier "lead" et découvrir des médicaments
|
WO2005027968A1
(fr)
|
2003-09-19 |
2005-03-31 |
Eisai Co., Ltd. |
Medicament contre le syndrome de down
|
EP1670510A1
(fr)
|
2003-09-24 |
2006-06-21 |
Peter Krammer |
Anticorps diriges contre les annexines, leur utilisation a des fins therapeutiques et diagnostiques, utilisation des annexines a des fins therapeutiques et diagnostiques
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
PT1678209E
(pt)
|
2003-10-07 |
2011-06-30 |
Yeda Res & Dev |
Anticorpos para a nik, a sua preparação e a sua utilização
|
WO2005037209A2
(fr)
|
2003-10-14 |
2005-04-28 |
University Of South Florida |
Procede pour separer un anticorps anti amyloide beta avec un peptide amyloide beta
|
CN1867828B
(zh)
|
2003-10-15 |
2010-09-29 |
第一化学药品株式会社 |
脂连蛋白多聚体的分离测定方法
|
EP1684574A4
(fr)
|
2003-10-20 |
2008-08-06 |
Envivo Pharmaceuticals Inc |
Mouches transgeniques exprimant un mutant alpha42
|
CA2543329A1
(fr)
|
2003-10-24 |
2005-05-06 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Commutateurs geniques orthogonaux
|
WO2005044306A2
(fr)
|
2003-11-04 |
2005-05-19 |
Chiron Corporation |
Utilisation d'anticorps antagonistes anti-cd40 pour le traitement de maladies autoimmunes et inflammatoires et le rejet d'organes transplantes
|
EP1690870B1
(fr)
|
2003-11-05 |
2012-03-28 |
Immuno-Biological Laboratories Co., Ltd. |
Peptide marqueur pour la maladie d'alzheimer
|
EP1694816B1
(fr)
|
2003-11-07 |
2013-08-28 |
Ciphergen Biosystems, Inc. |
Biomarqueurs pour la maladie d'alzheimer
|
US20070264280A1
(en)
|
2003-11-07 |
2007-11-15 |
Federoff Howard J |
Compositions and Methods for Treating Neurological Diseases
|
US7674599B2
(en)
|
2003-11-08 |
2010-03-09 |
Elan Pharmaceuticals, Inc. |
Methods of using antibodies to detect alpha-synuclein in fluid samples
|
KR100556660B1
(ko)
*
|
2003-11-11 |
2006-03-10 |
국립암센터 |
Hgf의 중화가능 에피토프 및 이에 결합하는 중화 항체
|
US20050226863A1
(en)
|
2003-11-20 |
2005-10-13 |
Massachusetts Institute Of Technology |
Single-domain antibodies and uses thereof
|
RU2006122946A
(ru)
|
2003-11-28 |
2008-01-10 |
Астразенека Аб (Se) |
Антитела
|
JP4870348B2
(ja)
|
2003-12-04 |
2012-02-08 |
株式会社ペルセウスプロテオミクス |
細胞表面抗原に対する抗体取得とその抗原同定
|
WO2005058815A2
(fr)
|
2003-12-10 |
2005-06-30 |
Medarex, Inc. |
Anticorps ip-10 et leurs utilisations
|
EP1701968B1
(fr)
|
2003-12-17 |
2015-06-03 |
Wyeth LLC |
Conjugues porteurs de peptides immunogenes et procedes de production associes
|
EP2213684A3
(fr)
*
|
2003-12-22 |
2011-05-18 |
Glaxo Group Limited |
Anticorps nogo-a pour le traitement de la maladie d'Alzheimer
|
FI3718564T3
(fi)
|
2003-12-23 |
2023-12-15 |
Genentech Inc |
Uusia anti-IL 13 -vasta-aineita ja niiden käyttöjä
|
WO2005070965A2
(fr)
|
2004-01-21 |
2005-08-04 |
Five Prime Therapeutics, Inc. |
Compositions pharmaceutiques contenant des antagonistes a lrp4, lrp8 ou a la megaline pour le traitement de maladies
|
WO2005072777A2
(fr)
|
2004-01-28 |
2005-08-11 |
Curix Aps |
Methodes de prevention et de traitement de la maladie d'alzheimer et d'autres maladies associees aux amyloides
|
US7238788B2
(en)
|
2004-02-18 |
2007-07-03 |
University Of Iowa Foundation |
Antibodies to phosphorylated tau, methods of making and methods of use
|
US7807157B2
(en)
*
|
2004-02-20 |
2010-10-05 |
Intellect Neurosciences Inc. |
Monoclonal antibodies and use thereof
|
ATE534667T1
(de)
|
2004-02-23 |
2011-12-15 |
Lilly Co Eli |
Anti-abeta antikörper
|
JP2008507255A
(ja)
|
2004-03-12 |
2008-03-13 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
ヒトgタンパク質ケモカインレセプター(ccr5)hdgnr10
|
US20080057057A1
(en)
|
2004-03-18 |
2008-03-06 |
Applied Research Systems Ars Holding N.V. |
Anti-Lipid Rafts Antibodies
|
CN1314805C
(zh)
|
2004-03-26 |
2007-05-09 |
中国人民解放军军事医学科学院放射与辐射医学研究所 |
一种新型促细胞凋亡素(apo)及其抗体,制备及用途
|
BRPI0509367A
(pt)
|
2004-03-30 |
2007-09-11 |
Glaxo Group Ltd |
anticorpo, fragmento de ligação de antìgeno, composição farmacêutica, métodos de tratar um paciente humano afligido com uma doença ou distúrbio, de triar um anticorpo, e de detectar hosm em uma amostra biológica, uso de um anticorpo terapêutico ou fragmento de ligação de antìgeno, medicamento, vetor, polunucleotìdeo, célula hospedeira recombinante estavelmente transformada ou transfectada, e, processo para a fabricação de um anticorpo terapêutico
|
US20070202547A1
(en)
|
2004-04-02 |
2007-08-30 |
Coburn Craig A |
Methods For Detecting Substances Which Bind To The Amyloid Precursor Protein Or Beta Amyloid Fragments, And Binding Compounds
|
US20060099211A1
(en)
|
2004-04-12 |
2006-05-11 |
Carmen Monthe |
Safer, more potent human immunoglobulin preparations for treating Alzheimer's disease
|
WO2005100584A2
(fr)
|
2004-04-15 |
2005-10-27 |
Glycofi, Inc. |
Production de glycoproteines galactosylatees dans des eucaryotes inferieurs
|
WO2005108378A2
(fr)
|
2004-04-15 |
2005-11-17 |
Samaritan Pharmaceuticals, Inc. |
(4-alkylpiperazinyl)(phenyl) methanones
|
CA2564432A1
(fr)
|
2004-04-27 |
2005-11-10 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Anticorps de .beta. peptide antiamyloide humain et fragment anticorps de celui-ci
|
ITRM20040212A1
(it)
|
2004-04-30 |
2004-07-30 |
Lay Line Genomics Spa |
Animale transgenico non umano come modello per malattie neurodegenerative e per la loro diagnosi precoce.
|
GR1005016B
(el)
|
2004-05-14 |
2005-10-11 |
BIOMENTIKA@ΛΑΙΦ@ΣΑΙΕΝΣΙΣ@ΑΝΩΝΥΜΗ@ΕΤΑΙΡΕΙΑ@ΦΑΡΜΑΚΕΥΑΤΙΚΩΝ@ΠΡΟΙΟΝΤΩΝ@(συμμετέχει@σε@ποσοστό@50%)@Α |
ΑΝΑΠΤΥΞΗ ΑΝΤΙΣΩΜΑΤΩΝ IgG KAI IgY ΕΝΑΝΤΙΟΝ ΕΙΔΙΚΟΥ ΣΥΝΘΕΤΙΚΟΥ ΕΠΙΤΟΠΙΚΟΥ ΠΑΡΑΓΩΓΟΥ ΤΗΣ HUMANIN (24-ΠΕΠΤΙΔΙΟΥ ΣΧΕΤΙΖΟΜΕΝΟΥ ΜΕ ΤΗ ΝΟΣΟ ALZHEIMER) ΙΚΑΝΩΝ ΝΑ ΑΝΙΧΝΕΥΟΥΝ ΤΟ ΒΙΟΔΡΑΣΤΙΚΟ 24-ΠΕΠΤΙΔΙΟ.
|
JP2008500286A
(ja)
|
2004-05-14 |
2008-01-10 |
ノースウエスタン ユニバーシティ |
Addl受容体を含む組成物、関連する組成物、および関連する方法
|
WO2005120571A2
(fr)
|
2004-06-07 |
2005-12-22 |
Ramot At Tel Aviv University Ltd. |
Procede d'immunisation passive contre des maladies ou des troubles caracterise(e)s par agregation amyloide a risque diminue de neuroinflammation
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
US20060018896A1
(en)
|
2004-06-10 |
2006-01-26 |
University Of Leicester |
Methods for treating conditions associated with lectin-dependent complement activation
|
US20050276806A1
(en)
|
2004-06-15 |
2005-12-15 |
Advanced Biotherapy, Inc. |
Treatment of autism
|
US20080124343A1
(en)
|
2004-06-18 |
2008-05-29 |
He Xu |
Treatment of Inappropriate Immune Responses
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
EP1769002A1
(fr)
|
2004-07-02 |
2007-04-04 |
Northwestern University |
Anticorps monoclonaux ciblant des ensembles pathologiques de beta-amyloides (abeta)
|
WO2006005588A1
(fr)
|
2004-07-12 |
2006-01-19 |
Geneprot, Inc. |
Especes de polypeptide convenant pour le traitement de troubles neurologiques
|
CN1721437A
(zh)
|
2004-07-13 |
2006-01-18 |
中南大学 |
一种与Tau蛋白相关的多肽抗原及抗体
|
AT500483B1
(de)
*
|
2004-07-13 |
2006-01-15 |
Mattner Frank Dr |
Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
WO2006006172A2
(fr)
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Utilisation d'agents anti-amyloides pour traiter et determiner des infections pathogenes
|
US7955812B2
(en)
|
2004-07-19 |
2011-06-07 |
The General Hospital Corporation |
Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
|
US7652003B2
(en)
|
2004-07-28 |
2010-01-26 |
Schering-Plough Corporation |
Macrocyclic β-secretase inhibitors
|
KR101068289B1
(ko)
|
2004-07-30 |
2011-09-28 |
리나트 뉴로사이언스 코퍼레이션 |
아밀로이드-베타 펩티드에 대해 지시된 항체 및 이의 사용 방법
|
ES2295949T3
(es)
|
2004-08-09 |
2008-04-16 |
Cellzome Ag |
Tratamiento de enfermedades neurodegenerativas mediante el uso de inhibidores de degs.
|
EP1776591B1
(fr)
|
2004-08-11 |
2013-10-16 |
Evotec International GmbH |
Applications diagnostiques et therapeutiques d'une atpase de la membrane plasmique
|
EP1787998A4
(fr)
|
2004-08-11 |
2008-08-27 |
Mitsubishi Chem Corp |
Anticorps et utilisation s'y rapportant
|
DE102004039326A1
(de)
|
2004-08-12 |
2006-02-16 |
Abbott Gmbh & Co. Kg |
Neue medizinische Verwendungen und Verfahren
|
US7335491B2
(en)
|
2004-08-27 |
2008-02-26 |
Wyeth Research Ireland Limited |
Production of anti-abeta
|
WO2006039470A2
(fr)
|
2004-09-29 |
2006-04-13 |
Centocor, Inc. |
Anticorps anti- amyloide, compositions, techniques et utilisations
|
WO2006039327A2
(fr)
|
2004-10-01 |
2006-04-13 |
Merck & Co., Inc. |
Procedes de traitement ou prophylaxie de maladies amyloidogeniques de l'oeil ou du nerf optique
|
ATE497508T1
(de)
|
2004-10-01 |
2011-02-15 |
Max Planck Gesellschaft |
Gegen das säugetier-eag1-ionenkanalprotein gerichtete antikörper
|
WO2006042158A2
(fr)
|
2004-10-05 |
2006-04-20 |
Wyeth |
Procedes et compositions permettant d'ameliorer la production de proteines recombinees
|
EP1811025A4
(fr)
|
2004-10-06 |
2008-02-06 |
Hiroshi Mori |
Proteine d'amyloide mutante
|
AU2005293752A1
(en)
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as Alzheimer's disease
|
WO2006047254A1
(fr)
|
2004-10-22 |
2006-05-04 |
Regents Of The University Of Minnesota |
Ensembles de proteines beta-amyloides oligomeres et utilisations de ceux-ci
|
BRPI0516962A
(pt)
|
2004-10-25 |
2008-09-30 |
Univ Northwestern |
anticorpo isolado, ou fragmento do mesmo, composição farmacêutica, métodos para prevenir a ligação de ligantes difundìveis derivados de abeta a um neurÈnio, para inibir a constituição de ligantes difundìveis, para bloquear a fosforilação de proteìna, para tratar profilaticamente ou terapeuticamente uma doença, para identificar um agente terapêutico, para detectar ligantes difundìveis, e para diagnosticar uma doença, e, kit para detectar ligantes difundìveis
|
WO2006047670A2
(fr)
|
2004-10-26 |
2006-05-04 |
Wyeth |
Procedes permettant d'evaluer les anticorps diriges contre des antigenes associes aux maladies neurodegeneratives
|
WO2006050041A2
(fr)
|
2004-10-28 |
2006-05-11 |
Ramot At Tel Aviv University Ltd. |
Procedes pour reduire ou inhiber une inflammation cerebrale ou pour promouvoir une neurogenese
|
JPWO2006046644A1
(ja)
|
2004-10-28 |
2008-05-22 |
三光純薬株式会社 |
アルツハイマー病の検定方法及び診断試薬
|
AU2005304707A1
(en)
|
2004-11-08 |
2006-05-18 |
Nanobac Pharmaceuticals Incorporated |
Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes
|
US7709208B2
(en)
|
2004-11-08 |
2010-05-04 |
New York University |
Methods for diagnosis of major depressive disorder
|
CN1772766A
(zh)
|
2004-11-12 |
2006-05-17 |
中国科学院上海生命科学研究院 |
抗细胞凋亡相关乙酰胆碱酯酶单克隆抗体及其用途
|
MX2007005870A
(es)
|
2004-11-17 |
2007-10-10 |
Joanne Mclauring |
Composiciones que comprenden derivados de escilo-inositol y metodos para tratar trastornos de agregacion de proteinas.
|
WO2006066118A2
(fr)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Conditionnement contextuel des peurs pour predire l'efficacite immunotherapeutique
|
TW200635608A
(en)
|
2004-12-15 |
2006-10-16 |
Neuralab Ltd |
Aβ antibodies for use in improving cognition
|
AR052051A1
(es)
|
2004-12-15 |
2007-02-28 |
Neuralab Ltd |
Anticuerpos ab humanizados usados en mejorar la cognicion
|
WO2006066233A1
(fr)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Essai d'immunoprecipitation permettant de predire l'efficacite in vivo d'anticorps anti-proteine beta-amyloide
|
AR051528A1
(es)
*
|
2004-12-15 |
2007-01-17 |
Neuralab Ltd |
Anticuerpos humanizados que reconocen el peptido beta amiloideo
|
JP2006166879A
(ja)
|
2004-12-20 |
2006-06-29 |
Japan Health Science Foundation |
Ab−dip、並びにアルツハイマー病の予防及び治療剤
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
WO2006067792A2
(fr)
|
2004-12-22 |
2006-06-29 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Autoantigenes de l'aldolase utiles pour le diagnostic et le traitement de la maladie d'alzheimer
|
WO2006069081A2
(fr)
|
2004-12-22 |
2006-06-29 |
Washington University In St. Louis |
Utilisation d'anticorps anti-a$g(b) pour le traitement d'un traumatisme cerebral
|
EP1676859A1
(fr)
|
2004-12-30 |
2006-07-05 |
Pevion Biotech Ltd. |
Compositions immunogènes contenant des peptides cycliques derivés du peptide beta-amyloide
|
EP1853299A4
(fr)
|
2005-01-14 |
2009-11-11 |
Univ California |
Compositions et methodes d'inhibition de la formation de drusen et methodes de diagnostic ou de traitement de pathologies liees aux drusen
|
CA2589860A1
(fr)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Anticorps anti-amyloide humanise
|
GT200600031A
(es)
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
JP2006213621A
(ja)
|
2005-02-02 |
2006-08-17 |
Japan Health Science Foundation |
Adoplinタンパク質、およびその利用
|
US20070082350A1
(en)
|
2005-02-09 |
2007-04-12 |
Philip Landfield |
Assay and method for diagnosing and treating alzheimer's disease
|
US7700099B2
(en)
|
2005-02-14 |
2010-04-20 |
Merck & Co., Inc. |
Non-immunostimulatory antibody and compositions containing the same
|
US7731962B2
(en)
*
|
2005-02-14 |
2010-06-08 |
Merck & Co., Inc. |
Anti-ADDL monoclonal antibody and use thereof
|
GB0503434D0
(en)
|
2005-02-18 |
2005-03-30 |
Senexis Ltd |
Amyloid-binding peptides, analogues and uses thereof
|
EP1853313B1
(fr)
|
2005-03-03 |
2018-01-24 |
Immunomedics Inc. |
Anticorps humanises l243
|
CN101171263A
(zh)
|
2005-03-04 |
2008-04-30 |
比奥根艾迪克Ma公司 |
通过合理修饰互补决定区残基使免疫球蛋白可变区人源化的方法
|
EP1861422B1
(fr)
|
2005-03-05 |
2010-02-24 |
Abbott GmbH & Co. KG |
Methode de criblage, procede servant a purifier des a-beta oligomeres non diffusibles, anticorps selectifs contre les dits a-beta oligomeres non diffusibles et procede servant a preparer ces anticorps
|
US20080152644A1
(en)
|
2005-03-07 |
2008-06-26 |
Ho-Juhn Song |
Genes Involved in Neurodegenerative Conditions
|
ES2259270B1
(es)
|
2005-03-09 |
2007-11-01 |
Consejo Superior De Investigaciones Cientificas |
Metodo de diagnostico in vitro de la enfermedad de alzheimer mediante un anticuerpo monoclonal.
|
WO2006099543A2
(fr)
|
2005-03-15 |
2006-09-21 |
The Regents Of The University Of California |
Methodes d'evaluation de la toxicite induite par des anticorps
|
WO2006100679A2
(fr)
|
2005-03-22 |
2006-09-28 |
Quark Pharmaceuticals, Inc. |
Anticorps de recombinaison diriges contre la transglutaminase humaine de type ii et utilisations de ces anticorps
|
JP2006265189A
(ja)
|
2005-03-24 |
2006-10-05 |
Kyoto Univ |
βアミロイドペプチド、及びそれを用いたアルツハイマー病治療薬又は予防薬のスクリーニング方法
|
ES2318918B1
(es)
|
2005-04-01 |
2010-02-16 |
Biotherapix Molecular Medicines, S.L.U. |
Anticuerpos humanos con capacidad de union al peptido beta-amiloide y sus aplicaciones.
|
WO2006110748A2
(fr)
|
2005-04-08 |
2006-10-19 |
The University Of Maryland, Baltimore |
Gene de reponse au complement 32 (rgc-32) lors d'une maladie
|
US20060241038A1
(en)
|
2005-04-20 |
2006-10-26 |
Eisai Co., Ltd. |
Therapeutic agent for Abeta related disorders
|
KR20070122497A
(ko)
|
2005-04-22 |
2007-12-31 |
제넨테크, 인크. |
Cd20 항체로 치매 또는 알츠하이머병을 치료하는 방법
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
WO2006119449A2
(fr)
|
2005-05-04 |
2006-11-09 |
Vectorlogics, Inc. |
Adenovirus modifie contenant un anticorps stabilise
|
EP1879613B1
(fr)
|
2005-05-05 |
2011-11-30 |
Merck Sharp & Dohme Corp. |
Compositions à base de conjugués peptidiques et méthodes destinées à la prévention et au traitement de la maladie d'alzheimer
|
US20090172827A1
(en)
|
2005-05-27 |
2009-07-02 |
Johannes Pohlner |
Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases
|
CA2607852A1
(fr)
|
2005-05-27 |
2006-11-30 |
Memory Pharmaceuticals Corp. |
Vecteurs de modeles de souris transgeniques alzheimer et leurs utilisations
|
NZ563941A
(en)
|
2005-06-06 |
2011-09-30 |
Wyeth Corp |
Anti-TRKB monoclonal antibodies and uses thereof
|
WO2006138553A2
(fr)
|
2005-06-17 |
2006-12-28 |
Wyeth |
Procedes de purification des proteines contenant la region fc
|
JPWO2006137354A1
(ja)
|
2005-06-21 |
2009-01-15 |
株式会社医学生物学研究所 |
アミロイド線維形成に対する阻害活性を有する抗体
|
TW200726774A
(en)
|
2005-06-30 |
2007-07-16 |
Merck & Co Inc |
Composition and method for producing stable amyloid beta oligomers
|
TW200726482A
(en)
|
2005-06-30 |
2007-07-16 |
Merck & Co Inc |
Method for preparing a covalently cross linked oligomer of amyloid beta peptides
|
EP2238986A3
(fr)
|
2005-07-08 |
2010-11-03 |
Biogen Idec MA Inc. |
Anticorps Sp35 et utilisations associées
|
WO2007011639A2
(fr)
|
2005-07-13 |
2007-01-25 |
Coimmune Inc. |
Immunoglobulines catalytiques
|
US7666886B2
(en)
|
2005-07-15 |
2010-02-23 |
The Regents Of The University Of California |
Compounds and methods for the diagnosis and treatment of amyloid associated diseases
|
CA2618508A1
(fr)
|
2005-08-10 |
2007-02-22 |
Oklahoma Medical Research Foundation |
Compositions de memapsine 2 tronquee et traitements associes
|
EA015629B1
(ru)
|
2005-08-11 |
2011-10-31 |
Арпи Матоссиан-Роджерс |
Пептиды, используемые для лечения и диагностики аутоиммунных заболеваний
|
JP2009504685A
(ja)
|
2005-08-15 |
2009-02-05 |
アラーナ・テラピューティクス・リミテッド |
新世界霊長類フレームワーク領域を用いる設計された抗体
|
US8124076B2
(en)
|
2005-08-18 |
2012-02-28 |
Ramot At Tel Aviv University Ltd. |
Single chain antibodies against β-amyloid peptide
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
JP2007077103A
(ja)
|
2005-09-16 |
2007-03-29 |
Yokohama City Univ |
アルツハイマー病の予防又は治療剤
|
CN101321863A
(zh)
|
2005-10-03 |
2008-12-10 |
阿斯利康(瑞典)有限公司 |
具有受调控的血浆半衰期的融合蛋白
|
JP5686953B2
(ja)
|
2005-10-11 |
2015-03-18 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハー |
交差種特異的(cross−species−specific)抗体を含む組成物および該組成物の使用
|
KR101691692B1
(ko)
|
2005-10-21 |
2016-12-30 |
카탈리스트 바이오사이언시즈, 인코포레이티드 |
보체 활성화를 억제하는 변형된 프로테아제
|
US20070092508A1
(en)
|
2005-10-21 |
2007-04-26 |
Recombiant Technologies, Llc |
Detoxification depot for Alzheimer's disease
|
AU2006306553B9
(en)
|
2005-10-21 |
2011-09-29 |
Merck Sharp & Dohme Corp. |
Anti-ADDL monoclonal antibody and use thereof
|
BRPI0618217A2
(pt)
|
2005-11-01 |
2011-08-23 |
Novartis Ag |
usos de anticorpos anti-cd40
|
WO2007059135A2
(fr)
|
2005-11-10 |
2007-05-24 |
Satoris, Inc. |
Procedes destines a traiter la maladie d’alzheimer
|
US8316104B2
(en)
|
2005-11-15 |
2012-11-20 |
California Institute Of Technology |
Method and apparatus for collaborative system
|
US20080014596A1
(en)
|
2005-11-16 |
2008-01-17 |
Jasna Jerecic |
ADDL Binding to Hippocampal Neurons
|
EP1951892A4
(fr)
|
2005-11-22 |
2009-01-14 |
Univ Pennsylvania |
Traitement par anticorps de la maladie d'alzheimer et des maladies connexes
|
KR101906161B1
(ko)
|
2005-11-30 |
2018-10-11 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
CA2637472A1
(fr)
|
2005-11-30 |
2007-06-07 |
Abbott Laboratories |
Procedes de preparation de formes recombinees de la proteine beta-amyloide humaine et utilisation desdites proteines
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
EP1973951A2
(fr)
|
2005-12-02 |
2008-10-01 |
Genentech, Inc. |
Polypeptides de liaison avec des sequences de diversite limitees
|
WO2007067512A2
(fr)
|
2005-12-08 |
2007-06-14 |
Merck & Co., Inc. |
Procede pour identifier des modulateurs d'adprh convenant pour traiter la maladie d'alzheimer
|
RS53291B
(en)
|
2005-12-12 |
2014-08-29 |
Ac Immune S.A. |
BETA 1-42 SPECIFIC MONOCLONIC ANTIBODIES WITH THERAPEUTIC PROPERTIES
|
AR057233A1
(es)
|
2005-12-12 |
2007-11-21 |
Hoffmann La Roche |
Glicosilacion en la region variable
|
KR101152557B1
(ko)
|
2005-12-12 |
2012-09-07 |
에이씨 이뮨 에스.에이. |
치료 백신
|
JP5358187B2
(ja)
|
2005-12-15 |
2013-12-04 |
ジェネンテック, インコーポレイテッド |
ポリユビキチンを標的とする方法と組成物
|
US20080058276A1
(en)
*
|
2006-01-13 |
2008-03-06 |
Cornell Research Foundation, Inc. |
Alzheimer's disease therapeutics based on pin-1 catalyzed conformational changes in phosphorylated amyloid precursor protein
|
EP1811304A1
(fr)
|
2006-01-18 |
2007-07-25 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Grandes particules de liaison de peptide Aß (LAPS) dans le diagnostic et la thérapie de la maladie d'Alzheimer
|
CN1329413C
(zh)
|
2006-01-23 |
2007-08-01 |
南京医科大学 |
一种治疗或预防老年性痴呆的抗体及其表达载体和在制药中的应用
|
PL1981540T3
(pl)
|
2006-01-30 |
2013-08-30 |
Grifols Therapeutics Inc |
Sposób leczenia i profilaktyki chorób związanych z odkładaniem się amyloidu z zastosowaniem IgM
|
GB0601976D0
(en)
|
2006-02-01 |
2006-03-15 |
Merck Sharp & Dohme |
Proteins
|
WO2007088712A1
(fr)
|
2006-02-02 |
2007-08-09 |
National University Corporation Nagoya University |
Inhibiteur de la mort des cellules neuronales et procédé de criblage
|
US20080045499A1
(en)
|
2006-02-06 |
2008-02-21 |
Elan Pharmaceuticals, Inc. |
Preferential Inhibition of Presenilin-1
|
CA2637775A1
(fr)
|
2006-02-09 |
2007-08-16 |
Novartis Ag |
Agents de liaison de la proteine-4 apparentee a frizzled (sfrp-4)
|
AU2007217039A1
(en)
|
2006-02-21 |
2007-08-30 |
Oklahoma Medical Research Foundation |
Treatment of Alzheimer's disease with inhibitors of APoE binding to APoE receptor
|
US20070196367A1
(en)
|
2006-02-22 |
2007-08-23 |
Valentin Dinu |
Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
|
US8034353B2
(en)
|
2006-02-22 |
2011-10-11 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody
|
EP1996227A2
(fr)
|
2006-02-24 |
2008-12-03 |
CHIESI FARMACEUTICI S.p.A. |
Compositions immunogenes anti-amyloïde, procedes et utilisations
|
US20100196932A1
(en)
|
2006-03-02 |
2010-08-05 |
The Board Of Trustees Of The University Of Illinois |
Yeast Reporter System
|
JP5823663B2
(ja)
|
2006-03-03 |
2015-11-25 |
プロミス ニューロサイエンシズ インコーポレイテッド |
ミスフォールドsod1媒介疾患を処置および検出するための方法および組成物
|
WO2007109107A2
(fr)
|
2006-03-17 |
2007-09-27 |
The Trustees Of Columbia University In The City Of New York |
Atf4 utilisé comme cible thérapeutique dans la maladie d'alzheimer et autres troubles neurologiques
|
BRPI0708970A2
(pt)
|
2006-03-21 |
2011-06-21 |
Wyeth Corp |
método para o tratamento de um sujeito com uma doença ou transtorno caracterizado por depósito amilóide de a-beta; método de inibição ou redução da acumulação de depósito amilóide de a-beta em um sujeito; método de inibição ou redução da neurodegeneração em um sujeito; e método de inibição ou redução do declìnio cognitivo, ou de melhora da cognição, em um sujeito
|
DK2004688T4
(da)
|
2006-03-23 |
2014-05-12 |
Bioartic Neuroscience Ab |
Forbedrede selektive protofibrille antistoffer og anvendelsen deraf
|
US20100029654A1
(en)
|
2006-03-23 |
2010-02-04 |
Mount Sinai School Of Medicine |
Cardiovascular compositions and use of the same for the treatment of alzheimer's disease
|
CA2541522A1
(fr)
|
2006-03-28 |
2007-09-28 |
E. Rick Preddie |
Dosage immunoenzymatique double pour detecter la maladie de l'alzheimer avec applications pour des vaccins therapeutiques visant a enrayer la maladie
|
KR101263294B1
(ko)
|
2006-03-30 |
2013-06-04 |
글락소 그룹 리미티드 |
아밀로이드베타 펩티드에 대한 항체
|
FR2899107B1
(fr)
|
2006-03-30 |
2008-06-13 |
Neurokin Entpr Unipersonnelle |
Utilisation de la (s)-roscovitine pour la fabrication d'un medicament
|
AU2007241056A1
(en)
|
2006-03-31 |
2007-11-01 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer's disease and improving normal memory
|
EP2006392B1
(fr)
|
2006-04-13 |
2013-03-27 |
EIDIA Co., Ltd. |
METHODE POUR DEPISTER LA MALADIE D'ALZHEIMER PAR DOSAGE DU TAUX DE DEGRADATION DE beta-AMYLOIDE DANS LE SANG ET REACTIF DE DIAGNOSTIC
|
CN101058608B
(zh)
|
2006-04-21 |
2011-02-23 |
杜如昱 |
人类抗Aβ1-32淀粉样蛋白抗体、其纯化方法及用途
|
KR101188861B1
(ko)
|
2006-04-21 |
2012-10-08 |
주식회사 피플바이오 |
삼차원적 상호작용을 이용하여 멀티머-형성 폴리펩타이드의 모노머로부터 멀티머를 분별 검출하는 방법
|
JP5311303B2
(ja)
|
2006-04-25 |
2013-10-09 |
国立大学法人 東京大学 |
アルツハイマー病および癌の治療薬
|
GB0608386D0
(en)
|
2006-04-27 |
2006-06-07 |
Senexis Ltd |
Compounds
|
WO2007127393A2
(fr)
|
2006-04-27 |
2007-11-08 |
The Mclean Hospital Corporation |
Méthodes de traitement et de criblage servant à promouvoir la neurogenèse
|
CA2650704A1
(fr)
|
2006-04-28 |
2007-11-08 |
Northwestern University |
Sels de composes de pyridazine
|
JP2007300856A
(ja)
|
2006-05-11 |
2007-11-22 |
Hiroshi Mori |
アミロイドタンパク質模倣物
|
US20070292895A1
(en)
|
2006-05-19 |
2007-12-20 |
Xiao-Ping Shi |
Assays and methods to detect beta-secretase and its activity in body fluids and tissue extracts
|
US8357781B2
(en)
*
|
2006-06-01 |
2013-01-22 |
Janssen Alzheimer Immunotherapy |
Neuroactive fragments of APP
|
US7479550B2
(en)
|
2006-06-02 |
2009-01-20 |
The Board Of Regents Of The University Of Texas System |
Amyloid β gene vaccines
|
JP4933159B2
(ja)
|
2006-06-02 |
2012-05-16 |
国立大学法人金沢大学 |
アルツハイマー病の診断方法
|
US7427342B2
(en)
|
2006-06-02 |
2008-09-23 |
General Electric Company |
Method and apparatus for shifting current distribution in electrodeionization systems
|
WO2007144198A2
(fr)
|
2006-06-16 |
2007-12-21 |
Umc Utrecht Holding B.V. |
INHIBITEURS DU FPLR-1 (FLIPr ET TYPE FLIPr) À UTILISER DANS DES MALADIES IMPLIQUANT DES ÉPISODES INFLAMMATOIRES INDUITS PAR LES AMYLOÏDES ET DES MALADIES MÉDIÉES PAR LE COMPLEXE IMMUNITAIRE
|
TW200815469A
(en)
|
2006-06-23 |
2008-04-01 |
Astrazeneca Ab |
Compounds
|
WO2008002893A2
(fr)
|
2006-06-29 |
2008-01-03 |
Centocor, Inc. |
Anticorps anti-amyloïdes, compositions, procédés et utilisations
|
AU2007269090A1
(en)
*
|
2006-07-06 |
2008-01-10 |
Roskamp Research Llc |
Compounds and combinations thereof for inhibiting beta-amyloid production and methods of use thereof
|
KR20090031724A
(ko)
|
2006-07-13 |
2009-03-27 |
파커-한니핀 코포레이션 |
Emi 흡수 갭 필링 물질
|
CL2007002070A1
(es)
|
2006-07-14 |
2008-02-08 |
Ac Immune S A Genentech Inc |
Anticuerpo quimerico o humanizado, o fragmentos de ellos, que se adhieren especificamente a por lo menos un epitopo en la proteina beta-amiloide; molecula de acido nucleico que lo codifica; composicion que lo comprende; su uso para tratar enfermedade
|
WO2008008463A2
(fr)
|
2006-07-14 |
2008-01-17 |
Trustees Of Columbia University In The City Of New York |
PROCÉDÉS ET COMPOSITIONS SERVANT À DÉTECTER ET QUANTIFIER sAPPβ
|
ES2323725T3
(es)
|
2006-07-28 |
2009-07-23 |
Vista Ventures Gmbh |
Procedimiento para la deteccion de oligomeros de amiloide beta en fluidos corporales.
|
US7705475B2
(en)
*
|
2006-08-03 |
2010-04-27 |
Stats Chippac Ltd. |
Integrated circuit package system
|
JP2009545756A
(ja)
|
2006-08-04 |
2009-12-24 |
ロンザ バイオロジックス ピーエルシー |
タンパク質凝集を予測し凝集阻害物質を設計する方法
|
WO2008021296A2
(fr)
|
2006-08-14 |
2008-02-21 |
Thymon, L.L.C. |
Compositions et méthodes pour le traitement et la prévention de la maladie d'alzheimer
|
JP5959795B2
(ja)
|
2006-08-18 |
2016-08-02 |
アーメイゲン・テクノロジーズ・インコーポレイテッドArmagen Technologies, Inc. |
血液脳関門送達のための物質
|
WO2008051326A2
(fr)
|
2006-08-21 |
2008-05-02 |
President And Fellows Of Harvard College |
Identification de contactines et de cams l1 en tant que ligands pour la protéine précurseur amyloïde
|
WO2008070229A2
(fr)
|
2006-08-28 |
2008-06-12 |
Case Western Reserve University |
Détection d'agrégats pathogènes de protéine dans un échantillon par elisa homologue
|
US8372399B2
(en)
*
|
2006-08-31 |
2013-02-12 |
Cardiac Pacemakers, Inc. |
Bispecific antibodies and agents to enhance stem cell homing
|
CA2660732A1
(fr)
|
2006-08-31 |
2008-03-06 |
Biogen Idec Ma Inc. |
Procedes concernant l'administration peripherique de polypeptides du recepteur nogo
|
US20080118938A1
(en)
|
2006-09-06 |
2008-05-22 |
Lisbell Estrada |
Methods and Compositions for the Detection of Protein Folding Disorders
|
WO2008028939A1
(fr)
|
2006-09-08 |
2008-03-13 |
Vib Vzw |
moyens et procédés pour la production d'oligomères amyloïdes
|
WO2008030251A1
(fr)
|
2006-09-08 |
2008-03-13 |
Georgetown University |
Anticorps deglycosylés anti-bêta amyloïde
|
ES2307396B1
(es)
|
2006-09-14 |
2009-09-30 |
Fundacion Para Investigaciones Neurologicas (Fin) |
Sistemas de eliminacion de sustancias neurotoxicas causantes de enfermedades neurodegenerativas mediante su atrapamiento selectivo por inmunoafinidad en el liquido cefalo-raquideo circulante.
|
US7375190B2
(en)
|
2006-09-19 |
2008-05-20 |
National Yang-Ming University |
Recombinant protein and method of screening for agents that modulate polypeptide aggregation
|
SI2074145T1
(sl)
|
2006-10-02 |
2017-12-29 |
Ac Immune S.A. |
Humanizirano protitelo proti amiloid beta
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
US20100104577A1
(en)
|
2006-10-10 |
2010-04-29 |
Golde Todd E |
Methods and materials related to anti-a (beta) antibodies
|
JP5153114B2
(ja)
|
2006-10-12 |
2013-02-27 |
知宏 千葉 |
新規のアルツハイマー病検出方法
|
US20080113444A1
(en)
|
2006-10-17 |
2008-05-15 |
Pray Todd R |
Method for detecting oligermization of soluble amyloid beta oligomers
|
GB0620735D0
(en)
|
2006-10-18 |
2006-11-29 |
Ares Trading Sa |
Proteins
|
KR100883132B1
(ko)
|
2006-10-24 |
2009-02-10 |
재단법인서울대학교산학협력재단 |
아밀로이드 형성 펩타이드 또는 단백질의 가용성 회합체에선택적으로 작용하는 절단제
|
NZ597676A
(en)
|
2006-10-27 |
2013-07-26 |
Abbvie Biotechnology Ltd |
Crystalline anti-hTNFalpha antibodies
|
EP2083621A4
(fr)
|
2006-11-20 |
2010-03-24 |
Satori Pharmaceuticals Inc |
Modulateurs de la production de bêta-amyloïde
|
WO2008064244A2
(fr)
|
2006-11-20 |
2008-05-29 |
The Trustees Of Columbia University In The City Of New York |
Modulation des phosphoinositides pour le traitement de maladies neurodégénératives
|
CA2670418A1
(fr)
|
2006-11-24 |
2008-05-29 |
Ac Immune Sa |
Nouveaux composes destines au traitement de maladies associes a des proteines amyloides ou de type amyloide
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
EP2094730A4
(fr)
|
2006-12-07 |
2010-08-04 |
Mayo Foundation |
Procédés et matériaux associés à des anticorps anti-amyloïdes
|
CN101553504A
(zh)
|
2006-12-11 |
2009-10-07 |
豪夫迈·罗氏有限公司 |
Aβ抗体胃肠外制剂
|
US20100028333A1
(en)
|
2006-12-15 |
2010-02-04 |
Getty Krista L |
Receptor for amyloid beta and uses thereof
|
SI2104682T1
(sl)
|
2007-01-11 |
2017-05-31 |
Michael Bacher |
Diagnostika in zdravljenje Alzheimerjeve bolezni in drugih nevrodementnih bolezni
|
WO2008140639A2
(fr)
|
2007-02-08 |
2008-11-20 |
Oligomerix, Inc. |
Biomarqueurs et dosages pour la maladie d'alzheimer
|
KR100806914B1
(ko)
|
2007-02-14 |
2008-02-22 |
경북대학교 산학협력단 |
퇴행성 신경질환의 예방 및 치료를 위한 리포칼린 2의 신규한 용도
|
WO2008104385A1
(fr)
|
2007-02-27 |
2008-09-04 |
Abbott Gmbh & Co. Kg |
Méthode de traitement d'amyloïdoses
|
US20100311767A1
(en)
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
GB0704394D0
(en)
|
2007-03-07 |
2007-04-11 |
Senexis Ltd |
Compounds
|
US20090022728A1
(en)
|
2007-03-09 |
2009-01-22 |
Rinat Neuroscience Corporation |
Methods of treating ophthalmic diseases
|
EP1978035A1
(fr)
|
2007-04-05 |
2008-10-08 |
Hans-Knöll-Institut Leibniz-Institut für Naturstoff-Forschung |
Anticorps anti-amyloïdes et leur utilisation dans le diagnostic et la thérapie des maladies amyloïdes
|
AU2008238577B2
(en)
|
2007-04-12 |
2015-02-19 |
Waratah Pharmaceuticals Inc. |
Use of cyclohexanehexol derivatives in the treatment of ocular diseases
|
KR20100016661A
(ko)
|
2007-04-18 |
2010-02-12 |
얀센 알츠하이머 이뮤노테라피 |
대뇌 아밀로이드 혈관병증의 예방 및 치료
|
CA2683053A1
(fr)
|
2007-04-19 |
2008-10-30 |
Vib Vzw |
Compositions d'oligonucleotides pour le traitement de la maladie d' alzheimer
|
US9217036B2
(en)
|
2007-04-26 |
2015-12-22 |
Yale University |
Prion protein as a receptor for amyloid-β oligomers
|
US20100178658A1
(en)
|
2007-05-30 |
2010-07-15 |
The Regents Of The University Of Michigan |
Screening assays for inhibitors of beta amyloid peptide ion channel formation
|
US20090232801A1
(en)
|
2007-05-30 |
2009-09-17 |
Abbot Laboratories |
Humanized Antibodies Which Bind To AB (1-42) Globulomer And Uses Thereof
|
US20090175847A1
(en)
|
2007-05-30 |
2009-07-09 |
Abbott Laboratories |
Humanized antibodies to ab (20-42) globulomer and uses thereof
|
CN101820911B
(zh)
|
2007-06-12 |
2015-05-06 |
Ac免疫有限公司 |
β淀粉样蛋白的人源化抗体
|
KR20160017126A
(ko)
|
2007-06-12 |
2016-02-15 |
에이씨 이뮨 에스.에이. |
모노클로널 항 베타 아밀로이드 항체
|
EP2009445A1
(fr)
|
2007-06-29 |
2008-12-31 |
Institut Pasteur |
Utilisation d'anticorps à domaine simple de chaînes pour détecter une formule oligomérique d'un peptide amyloide bêta et ses applications
|
CN101084909A
(zh)
|
2007-07-03 |
2007-12-12 |
福建医科大学附属协和医院 |
人参皂苷Rg1的新用途
|
MX2010000369A
(es)
|
2007-07-12 |
2010-07-02 |
Acumen Pharmaceuticals Inc |
Metodos para mejorar la funcion cognitiva usando compuestos no peptidicos.
|
US8962677B2
(en)
*
|
2007-07-12 |
2015-02-24 |
Acumen Pharmaceuticals, Inc. |
Methods of restoring cognitive ability using non-peptidic compounds
|
CA2692773A1
(fr)
|
2007-07-12 |
2009-01-15 |
Acumen Pharmaceuticals, Inc. |
Procedes de modification d'oligomeres amyloides .beta. au moyen de composes non peptidiques
|
EP2194975A2
(fr)
|
2007-07-12 |
2010-06-16 |
Acumen Pharmaceuticals, Inc. |
PROCÉDÉS CONSISTANT À INHIBER LA FORMATION DE LIGANDS DIFFUSABLES D'AMYLOIDE-ß UTILISANT DES COMPOSÉS D'ACYLHYDRAZIDE
|
US20100297012A1
(en)
|
2007-10-05 |
2010-11-25 |
Andrea Pfeifer |
Humanized antibody
|
RU2538709C2
(ru)
|
2007-10-05 |
2015-01-10 |
Дженентек, Инк. |
Гуманизированное антитело
|
CA2701793C
(fr)
|
2007-10-05 |
2017-04-25 |
Genentech, Inc. |
Utilisation d'anticorps beta anti-amyloides contre les maladies occulaires
|
GB0719559D0
(en)
|
2007-10-05 |
2007-11-14 |
Senexis Ltd |
Compounds
|
CN101152576A
(zh)
|
2007-10-15 |
2008-04-02 |
王延江 |
防治阿尔茨海默病的药物
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
MX2011000975A
(es)
|
2008-07-25 |
2011-05-25 |
Abbott Lab |
Analogos de peptido b amiloide, oligomeros de los mismos, procedimientos para preparar y composiciones que comprenden dichos analogos u oligomeros, y sus usos.
|
WO2010010469A2
(fr)
|
2008-07-25 |
2010-01-28 |
Abbott Gmbh & Co. Kg |
Oligomères abêta (x-38..43), et procédés, compositions, et utilisations associés
|
KR101529160B1
(ko)
|
2009-02-25 |
2015-06-16 |
아카데미아 시니카 |
B 림프구 상의 인간 mIgE에 결합 가능한 항-CεmX 항체
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
BR112012031915B1
(pt)
|
2010-06-14 |
2021-03-23 |
Esab Ab |
Método para ajustar automaticamente um parâmetro de soldagem mig/mag, controlador de soldagem para ajustar automaticamente um parâmetro de soldagem para soldagem mig/mag e máquina de soldagem mig/mag
|
US9062101B2
(en)
|
2010-08-14 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
JP2017532289A
(ja)
|
2014-07-07 |
2017-11-02 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
突然変異タンパク質アミロイドβ(Aβ)アミノ酸配列に基づく免疫原性産物およびその使用
|